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Autism is a neurodevelopmental disorder which is characterized by severe and pervasive 
impairment in reciprocal socialization, qualitative impairment in communication and 
repetitive or stereotyped behaviour associated to resistance to change. Oxytocin (OT) is a 
peptidic hormone best known for its role in lactation and parturition. Recently, it has been 
also shown by several studies involving different lines of knock-out mice to play an 
important role in the central nervous system (CNS) by acting on the regulation of social, 
emotional, aggressive behaviour and on learning and memory. Furthermore, prosocial 
effects following OT administration in humans have been shown. The link between OT 
and autism has already been traced in preliminary clinical studies as autism affected 
patients received a beneficial outcome from treatment with OT. Pharmacokinetic (very 
short half-life), pharmacodynamic (unspecific binding to vasopressin (AVP) receptors) 
properties and the presence of peripheral side effects of OT, though, make this peptide 
an unsuitable target for a future clinical use. It is important, in this perspective, to 
characterize specific animal models in order to validate the use of OT analogs with more 
suitable characteristics for preclinical research.  
To this end, a characterization of the behavioural phenotype of OTR knock-out mice 
(OTR-/-) and heterozygous littermates (OTR+/-) in comparison with their wild type 
counterparts (OTR+/+) has been carried out. General home cage behaviour, sensory, 
motor abilities and emotional behaviour were not affected by the altered genotype. 
Interestingly, both and OTR+/- and OTR-/- mice exhibited a significant social impairment as 
quantified in both the sociability and social novelty tests. Furthermore, OTR-/- mice 
displayed much higher levels of aggression when facing a stranger mouse as a higher 
number of attacks and tail rattlings has been registered in the neutral cage paradigm. 
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Moreover, when tested in the reversal phase of a T-maze task for their cognitive flexibility, 
OTR-/- showed a profound impairment in responding to the changes applied in their 
established routine. All in all, the OTR mutant mouse model provides full range autism-
related aberrant behaviours, displaying social impairments, altered aggressive behaviour, 
a strong resistance to change and stereotyped behaviour. Mechanisms underlying the 
aberrant phenotype revealed by mutant mice were investigated through autoradiographic 
binding experiments for both OTR and vasopressin 1A receptor (V1aR) distribution. In 
addition, pharmacological treatments with OT, AVP and V1aR antagonist SR49059 were 
done. Binding experiments were carried out in specific brain areas known to exert a key 
role in integrating the processing of olfactory information that is crucial to regulate social 
and emotional behaviour in rodents. OTR-/- animals displayed an almost undetectable 
OTR binding in all tested areas. Furthermore, a slight compensatory up-regulation of 
V1aR in the hippocampus and a significant down-regulation of the V1aR expression in 
the anterior olfactory nucleus, amygdala, ventral pallidum and lateral septum were found. 
As for heterozygous mutants their phenotype appeared as halfway between the wild type 
and knock out counterparts for OTR binding sites and V1aR binding has been subjected 
to a slight reduction in ventral pallidum and anterior olfactory nucleus only. Hence, the 
previously mentioned aberrant behavioural phenotype displayed by OTR mutant mice 
could be due to an altered OT/AVP receptors concentration in crucial brain areas. 
Interestingly, intracerebroventicular treatment with both OT and AVP (0.5ng/mouse) in 
mutant mice was able to rescue the impairment shown in all behavioural tasks. 
Furthermore, pre-treatment with V1aR antagonist SR49059 (0.5 ng/mouse), which per se 
did not exert any effect, in association with OT, blocked the social, aggressive and 
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cognitive enhancing effects of the neuropeptide. Our results suggest a strong involvement 
of AVP, alongside OT, and in particular the subtype 1A of the AVP receptor, in the 
modulation of social abilities and cognitive flexibility of OTR mutant mice. 
Finally, as an increasing interest for the use of zebrafish for social behavioural analyses 
to study the genetic basis of behaviour is rising, we also evaluated zebrafish potential as 
a screening tool for neuropsychiatric diseases involving deficits in social behaviour. To 
this end, we analyzed the effect of OT, AVP but most importantly isotocin (ISO) and 
vasotocin (AVT) (zebrafish homologues of OT and AVP, respectively) using the shoaling 
preference test as social paradigm. Dose-response parabolic curves were obtained and 
all neuropeptides showed significant efficacy in enhancing social interaction, suggesting 
the involvement of the oxytocin/vasopressin systems and their analogs in the modulation 
of zebrafish social behaviour.  
In conclusion, our findings indicate that OTR-/- and in part OTR+/- mice display autistic-like 
symptoms rescued by administration of AVP and OT to young adult animals. The OTR 
mutant mouse is thus instrumental to investigate the neurochemical and synaptic 
abnormalities underlying autistic-like disturbances and to test new strategies of 
pharmacological intervention. We also suggest the use of zebrafish as an alternative 
animal model for the study of social behaviour, especially as a screening tool: future 
studies involving new molecules acting on OT and AVP systems will be carried out, taking 
advantage of this new promising model. 
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2.1  Autism 
Autism is a neuropsychiatric disorder characterized by severe and pervasive 
impairment in reciprocal socialization, qualitative impairment in communication and 
repetitive or unusual behaviour (Levy et al., 2009). Clinicians and researchers use autism 
spectrum disorders (ASD) to include autism, Asperger‟s syndrome (a disease similar to 
autism with no cognitive deficit), and “pervasive developmental disorder not otherwise 
specified” (PDD-NOS).  
ASD prevalence seems to have increased greatly since the 1960s. In the 20 years 
since, in the USA and Europe prevalence rates ranged from 5 to 72 cases per 10 000 
children while prevalence of autistic disorder is now between ten and 20 per 10 000 
children (Newschaffer et al., 2007). A rise in the number of children identified with autism 
spectrum disorders in educational systems has resulted in public health concern 
(Shattuck, 2006): some of the reported increase is attributable to new classifications in 
education settings and the subsequent reclassification of children from a different 
category to autism. In fact symptoms of ASD might resemble or arise with intellectual 
disability, attention deficit-hyperactivity disorder, or obsessive-compulsive disorder 
(Gillberg et al., 2000), so policy and practice changes rather than true changes in 
community prevalence might be responsible for recorded increases. 
Core symptoms of autism spectrum disorders affect domains of socialization, 
communication, and behaviour (see panel 1 for details). Clinical signs are usually present 
by the age of 3 years, but typical language development might delay identification of 
symptoms (Levy et al., 2009). Results of prospective studies (Volkmar et al., 2008) of 
infants at risk (i.e. younger siblings of affected children) have shown that deficits in social 
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responsiveness, communication and play can be present in those as young as age 6–12 
months. Diagnoses show heterogeneity of clinical phenotype, severity, and type and 
frequency of symptoms.  
 
Panel 1: core domains of autism (adapted from Levy et al., 2009) 
 
2.1.1 Neurobiology of Autism 
Many studies have attempted to elucidate neurobiological features of autism by 
examining brain growth, functional neural networks, neuropathology, electrophysiology, 
and neurochemistry in both patients and animal models of the disease. 
Neurobiological ﬁndings support different theories. Macrocephaly is noted by age 
2–3 years in 20% of children with autism spectrum disorder. Brain growth accelerates at 
12 months (Minshew and Williams, 2007). These changes arise in parallel with onset of 
Socialization 
 Impaired use of non-verbal behaviours to regulate interactions 
 Delayed interactions, few or no friendships 
 Absence of seeking to share enjoyment and interests 
 Delayed initiation of interactions 
 
Communication 
 Delay in verbal language and non-verbal compensation with gestures 
 Impairment in expressive language and conversation 
 Stereotyped, repetitive language 
 Delayed imaginative and social imitative play 
 
Restricted, stereotyped and repetitive patterns of behaviour 
 Adherence to routines, rigidity and perseverative behaviour 
 Stereotyped and repetitive motor behaviour 
 Self-stimulatory behaviour 
 Fascination with parts of items and unusual visual exploration 
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core symptoms during the ﬁrst 2 years of life. Results of neuroimaging studies (Pardo and 
Eberhart, 2007) have shown overgrowth in cortical white matter and abnormal patterns of 
growth in the frontal lobe, temporal lobes, and limbic structures such as the amygdala. 
These brain regions are implicated in development of social, communication, and motor 
abilities that are impaired in ASD. In post-mortem brain studies (Schultz, 2005), 
researchers have also noted cytoarchitectural abnormal features, including reduced 
number and size of purkinje cells and abnormal ﬁndings in the cortical minicolumn. 
Functional MRI has shown differences in patterns of activation and timing of 
synchronisation across cortical networks, with lowered functional connectivity between 
language, working memory, social cognition or perception, and problem solving related 
breain areas. The most replicated functional MRI abnormal ﬁnding, though, is the 
hypoactivation of the fusiform face area, associated with deﬁcits in perception of people 
compared with objects (DiCicco-Bloom et al., 2006, Schultz, 2005). 
  
2.1.2. Genetics of Autism 
Before the 1970s, autism was not widely considered to have a strong biological 
basis. Instead, various psychodynamic interpretations, including the role of a cold style of 
mothering, were invoked as potential causes. The importance of genetic contributions 
became clear in the 1980s, when the co-occurrence of chromosomal disorders and rare 
syndromes with the ASD were noted (Blomquist et al., 1985). 
Several lines of evidence support genetic factors as a predominant cause of ASD. 
First is the growing body of literature demonstrating that mutations or structural variation 
in any of several genes can dramatically increase disease risk. Second, the relative risk 
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of a child being diagnosed with autism is increased at least 25-fold over the population 
prevalence in families in which a sibling is affected (Jorde et al., 1991). Third, siblings and 
parents of an affected child are more likely than controls to show subtle cognitive or 
behavioural features that are qualitatively similar to those observed in probands (Bishop 
et al., 2004).  
Different genes have been demonstrated to be involved in the pathogenesis of 
autism, including neuroligins, post-synaptic scaffold proteins, phosphatases and 
transcription factors (see tab. 1) 
Neuroligins interact with neurexins expressed in presynaptic neurons (Lise and El-
Husseini, 2006). The NLGN3 and NLGN4 genes have been found to be mutated in 1/100 
individuals with ASD (Lintas and Persico 2009). The clinical phenotype of human NLG 
mutation carriers is heterogeneous. Mutation carriers typically display no dysmorphic 
features but, interestingly, they can undergo regression at disease onset, characterized 
by a loss of initially acquired social and verbal milestones (regressive autism) (Jamain et 
al., 2003). The neurexin 1 gene (NRXN1) encodes a neurexin1 signal peptide variant. It is 
a neuronal cell-surface protein that may be involved in cell recognition and cell adhesion 
by forming intracellular junctions through binding to neuroligins. Neurexin1 gene 
mutations have been identiﬁed in individuals with autism (Yan et al., 2008).  
Another autism-related gene is SHANK3. Shank proteins are involved in the 
assembly of specialized postsynaptic structures and are required for the development of 
language and social communication. Recent studies conﬁrmed that SHANK3 mutations 
can cause ASD with phenotype characterized mainly by severe verbal and social deﬁcits 
(Moessner et al., 2004; Aneja and Tierney, 2008). 
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Tab 1: ASD related genes (taken from Caglayan, 2010) 
 
2.1.3 Autism Treatment 
Although many psychosocial interventions have some positive evidence, 
suggesting that some form of treatment is preferable to no treatment their clinical results 
are mostly tentative, and there is little evidence for the relative effectiveness of treatment 
options (Abrahams and Geschwind, 2008). Intensive special education programs and 
behavioural therapy early in life can help children with ASD acquire self-care, social, and 
job skills (Sigman et al., 2004), and can often improve functioning, decrease symptom 
severity and maladaptive behaviours (Arndt et al., 2005). Available approaches include 
applied behaviour analysis, developmental models, structured teaching, speech and 
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language therapy, social skills therapy, and occupational therapy (Levy et al., 2009) 
Educational interventions have some effectiveness in older children: intensive 
behavioural treatment has demonstrated effectiveness in enhancing global functioning in 
preschool children and is well-established for improving intellectual performance of young 
children (Arndt et al, 2005). 
Many drugs are prescribed to treat problems associated with ASD. A 2007 study 
on a U.S. population of children with ASD has shown that 83% had at least one drug 
claim during the year. Prescribed drugs for these children came from 125 different 
therapeutic classes. The seven most frequently prescribed classes of psychoactive drugs 
were antidepressants, stimulants, tranquilizers/antipsychotics, anticonvulsants, 
hypotensive agents, anxiolytic/sedative/hypnotics and benzodiazepines. Age data 
indicate that about 70% of 8-year old or older children with autism-spectrum disorders 
receive some form of psychoactive medication in a given year (Oswald and Sonenklar, 
2007). Aside from antipsychotics (Silverman, 2008) there is not much reliable research 
about the effectiveness or safety of drug treatments for adolescents and adults with ASD 
(Geschwind, 2008). A person with ASD may respond atypically to medications, the 
medications can have adverse effects, and still no known medication relieves autism's 
core symptoms of social and communication impairments (Rogers, 2009).  
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2.2. Neurohypophysial hormones 
2.2.1. Oxytocin (OT) 
Oxytocin (OT) is a nonapeptide hormone best known for its role in lactation and 
parturition. The word oxytocin was coined from the Greek words (ωκνε, τοκοχε) meaning 
“quick birth” after its uterine-contracting properties were discovered by Dale (1906). 
Shortly thereafter, the milk ejection property of OT was described (Ott and Scott, 1910; 
Schafer and Mackenzie, 1911). 
 
2.2.1.1. Structure and evolution of oxytocin 
OT is composed of nine amino acids (Cys–Tyr–Ile–Gln–Asn–Cys–Pro–Leu–Gly) 
with a sulfur bridge between the two cysteines. The structure of OT is very similar to 
another nonapeptide, vasopressin (AVP), which differs from OT by two amino acids only 
(Ile-Leu → Phe-Arg) (Fig 1).  
OT and AVP are neuropeptides that are evolutionarily well conserved across 
phyla. Amino acid substitutions occurred in precise positions. All vertebrate species 
possess an oxytocin-like and a vasopressin-like peptide so that two evolutionary lineages 
can be traced. Because a single peptide, vasotocin ([Ile3]-vasopressin or [Arg8]-oxytocin) 
has been found in the most primitive Cyclostomata, a primordial gene duplication and 
subsequent mutations are assumed to have given rise to the two lineages. They started 
with vasotocin ([Arg8]-vasotocin) and isotocin ([Ser4,Ile8]-oxytocin) in bony fishes and 
culminated with vasopressin and oxytocin in placental mammals. Mesotocin ([Ile3]-
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oxytocin), found in lungfishes, amphibians, reptiles, birds and marsupials, appears as an 
evolutionary intermediate. (Acher et al., 1995) 
As a result of gene duplication, the OT gene is located on the same chromosome 
(chromosome 2 in mice and 20 in humans) as AVP but is oriented in opposite 
transcriptional direction in mammals. Both OT and AVP contain three exons and two 
introns and are highly homologous. The two genes are separated by an intergenic region 
(IGR) that varies in length across species (e.g., 11 kb in rat and human, and 3.6 kb in 
mouse). The IGR harbors regulatory DNA sequences within conserved portions for both 
OT and AVP (Gainer et al., 2001). (Fig. 1) 
 
Fig. 1. Schematic diagram of the oxytocin (OT) and vasopressin genes (large arrows), 
preprohormones (boxes), and neuropeptides (bottom). Their human chromosomal location is shown at the 
top. Both genes are composed of three exons shown as small blue arrows and separated by two introns 
(shown as dotted lines between the exons). The genes are located on the same chromosome but are 
transcribed in opposite directions and separated by an intergenic region (IGR). The preprohormones each 
contain a signal peptide (SP), a neuropeptide (AVP or OT), and a neurophysin (NP). In the case of AVP, a 
glycopeptide (GP) as well is present. Protein processing signals are represented by thick lines. Cysteine 
residues form a disulﬁde bond to create a cyclic six amino acid ring for both neuropeptides. Seven out of 
the nine amino acids are identical in the neuropeptides and two are different (red). (Taken from Lee at al., 
2009). 
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Oxytocin is primarily synthesized in magnocellular neurons of the paraventricular 
(PVN) and supraoptic (SON) nuclei of the hypothalamus. The bulk of the peptide is 
transported to the posterior pituitary where it is released to regulate parturition and 
lactation. However, some of the OT is transported into the dendrites where regulation of 
its release is critical for controlling the ﬁring patterns of the OT neurons (Rossoni et al., 
2008). Lesser amounts of OT are generated by smaller, parvocellular neurons of the PVN 
and, depending on species, the bed nucleus of the stria terminalis (BNST), medial 
preoptic area, and lateral amygdala for release within the brain (Young and Gainer, 2003, 
2009).  
 
2.2.1.2. The oxytocin receptor 
Oxytocin is currently known to have only one receptor (OTR) (fig. 2), unlike AVP 
which has at least three different subtypes (V1aR, V1b, V2) (Caldwell et al., 2008). OT 
acts on OTR as a full agonist capable of promoting the promiscuous coupling of the 
receptor to different G proteins (G-protein coupled receptor, GPCR), resulting in the 
activation of multiple downstream signalling pathways (Reversi et al., 2005). Classically, 
OTR coupling to Gq is responsible of phospholipase C beta (PLCbeta) activation, 
followed by inositol phosphate (InsP) and diacylglicerol (DG) production, and release of 
Ca++ from intracellular stores. 
Centrally, AVP exerts its effects mainly through the vasopressin-1A receptor, 
which is also coupled to the PLC pathway (Thibonnier et al., 1998; Birnbaumer, 2000). 
Importantly, both OT and AVP, as well as the OTR and V1aR, display a high degree of 
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sequence homology, and both peptides can therefore activate both receptors (Chini and 
Manning, 2007). 
In freshly dissociated rat supraoptic neurons, OT and AVP induce a significant 
increase in the intracellular Ca++ concentration which persists in the absence of external 
Ca++, suggesting that it mainly involves Ca++ release from intracellular stores (Sabatier et 
al., 2004). Similar results have been also obtained in primary cultures of cerebral cortical 
astrocytes as well as in brain neurons derived from hippocampus, lamina terminalis of the 
subfornical organ and area postrema (Consolim-Colombo et al., 1996; Jurzak et al., 1995; 
Strosser et al., 2001). However, in vagal motor neurons of brainstem slices, the OT-
evoked current is not mediated by an increase in Ca++ concentration, indicating that in 
these cells OTR is not functionally coupled to PLCbeta (Alberi et al., 1997). Thus, the 
peptide-activated second messengers pathways may be different in different neuronal 
populations and/or at different stages of neuronal development (Raggenbass, 2001). 
In general, OTR is widely distributed throughout the brain. In rodents, it is often 
especially prominent in the olfactory bulb and tubercle, neocortex, endopiriform cortex, 
hippocampal formation (especially subiculum), central and lateral amygdala, BNST, 
nucleus accumbens (NAc), and ventromedial hypothalamus (VMH) (Insel et al., 1991; 
Veinante and Freund-Mercier, 1997). In humans, expression is prominent in the basal 
nucleus of Meynert, the nucleus of the vertical limb of the diagonal band of Broca, the 
ventral part of the lateral septal nucleus, the preoptic/anterior hypothalamic area, the 
posterior hypothalamic area, the substantia nigra pars compacta, the substantia 
gelatinosae of the caudal spinal trigeminal nucleus and of the dorsal horn of the upper 
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spinal cord, as well as in the medio-dorsal region of the nucleus of the solitary tract (Loup 
et al., 1989, 1991). 
 
 
 
Fig 2: Schematic structure of the human OT receptor with amino-acids residues shown in one-letter 
code. Residues conservative within the OT/AVP receptor subfamily are outlined in grey, and residues 
conservative for the whole GPCR superfamily are outlined in black (taken from Gimpl and Fahrenholz 
2001). 
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2. 2.2. Vasopressin (AVP) 
2.2.2.1. Properties and receptors 
AVP is mainly synthesized in the magnocellular cells of the hypothalamic 
supraoptic (SON) and paraventricular nuclei (PVN) whose axons project to the posterior 
pituitary (Young and Gainer, 2003). AVP is then released into the blood stream upon 
appropriate stimulation (for example, hemorrhage or dehydration) to act at the kidneys 
and blood vessels (Nishimura and Fan, 2003). The brain also contains several 
populations of smaller, parvocellular neurons whose projections remain within the brain. 
These populations are located within the PVN, bed nucleus of the stria terminalis (BNST), 
medial amygdala (MeA) and suprachiasmatic nucleus (SCN) (De Vries et al., 1985). 
There are three major receptor types for AVP: V1aR, V1bR, and V2R. The AVP receptors 
have seven transmembrane domains: V1aR and V1b couple to Gaq/11 GTP binding 
proteins which activate PLC activity whereas V2R couples to Gs and acts through the 
cyclic AMP system (Michell et al., 1979; Jard et al., 1987). Although not conﬁned to these 
tissues in the periphery, the V1aR is prominent in the liver, kidney and vasculature. The 
V1bR is prominent in the anterior pituitary in cells that make adrenocorticotropin hormone 
(Antoni, 1984) but is detected in many other tissues (Lolait et al., 1995). V2R is mainly 
expressed in the kidney and the antidiuretic function of AVP is mostly transduced via this 
receptor in the renal collecting duct (Bankir, 2001). The V1aR and V1bR are expressed 
throughout the brain, but evidence for the presence of the V2R there is scarce (Foletta et 
al., 2002).  
As for receptors localization within the brain, major V1aR binding is present in the 
rat lateral septum (LS), neocortical layer IV, hippocampal formation, amygdalostriatal 
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area, BNST, various hypothalamic areas, ventral tegmental area, substantia nigra, 
superior colliculus, dorsal raphe, nucleus of the solitary tract and inferior olive (Johnson et 
al., 1993). V1aR binding is moderate throughout the spinal cord, but binding is higher in 
the dorsolateral motoneurons in general and all motoneurons in the lumbar 5/6 levels, 
where innervation to the perineal muscles originates (Tribollet et al., 1997). It should be 
noted, however, that V1bR distribution has not been mapped by receptor autoradiography 
due to the lack of a speciﬁc radiolabeled ligand. 
 
2.2.3. OT, AVP and Autism 
 
Recently, researchers have begun to examine OT effects on human social 
recognition, primarily by testing recognition of faces and expressions. OT administered 
intranasally and intravenously to males and females after viewing male faces (with happy, 
angry, or neutral expressions) signiﬁcantly improves recognition memory 30 min and 24 h 
later for neutral and angry faces only (Savaskan et al., 2008). In contrast, an earlier study 
by the same group reports that OT (administered to males only) increases memory for 
previously seen faces with happy expressions only, not angry or neutral (Guastella et al., 
2008b, 2009). Why this discrepancy exists remains unclear, but may be due to 
presentation of different stimulus faces (male, male and female, drawings). In a more 
recent study, intranasal OT was given to male subjects 40 min prior to presentation of 
faces. Twenty-four hours later, subjects treated with OT had better memory for faces 
seen the previous day, with no inﬂuence on memory for previously seen non-social stimuli 
(Rimmele et al., 2009): this is a further indication that OT is speciﬁcally involved in 
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memory of social stimuli. OT in the medial amygdala underlies social recognition in 
rodents, as discussed previously. Similarly, the human amygdala seems important for 
facial recognition in humans. Lower blood oxygenation level dependent functional 
magnetic resonance imaging (fMRI) activity is seen in the right amygdala after intranasal 
OT, as compared with placebo, when viewing emotional (happy, fearful, or angry 
expressions) faces, regardless of type of emotion displayed (Domes et al., 2007). 
Similarly, male subjects have reduced amygdala activation when shown angry or fearful 
expressions following OT administration. The same reduction is not seen when presented 
with non-social stimuli, such as fearful or threatening scenes. Furthermore, functional 
amygdala connections to upper brainstem regions (such as the periaqueductal gray) are 
signiﬁcantly reduced with intranasal OT (Kirsch et al., 2005), indicating that OT can affect 
a circuit for social recognition and response. However, it should be noted that although 
intranasal application of large proteins may reach the olfactory bulbs and small peptides 
the cerebrospinal fluid (Born et al., 2002), no studies have shown that the intranasal OT is 
reaching the central nervous system areas involved in facial recognition. 
Animal studies of social cognition and the human research suggesting prosocial 
effects of OT have let researchers trace a link between this neuropeptide and autism. A 
few autism cases have been identiﬁed with deletions in chromosome 3 that essentially 
knock out the human oxytocin receptor. In particular, Gregory et al. reported on a deletion 
of the OTR in an autistic boy and his mother, who had obsessive-compulsive disorder. An 
affected brother did not have the OTR deletion but exhibited epigenetic silencing of the 
OTR due to hypermethylation of the OTR promoter. In an independent sample, they not 
only found additional autism cases with hypermethylation of the OTR gene but reported 
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reductions in OTR mRNA in temporal cortex associated with hypermethylation, 
demonstrating likely epigenetic silencing of the OTR even in the absence of a genetic 
mutation (Gregory et al., 2009). Many studies support the hypothesis that also early 
environmental experience, especially social experience, can have enduring effects on the 
OTR system (Carter et al., 2009). While there are many reports for associations between 
variations in OTR and AVP receptor genes and risk for autism, data are still not entirely 
consistent, as there is still little evidence that these variants are functional.  
Modahl and colleagues reported a marked reduction in OT in children with autism 
relative to age-matched controls (Modahl et al., 1998). There have been few attempts to 
replicate these ﬁndings, although profoundly reduced OT plasma levels have been 
reported in high-functioning autism patients (Andari et al., 2010). Cerebrospinal ﬂuid 
measures of OT could be informative but are not currently available from individuals with 
autism. It is notheworthy that cerebrospinal fluid OT has been reported to be selectively 
reduced in both women subjected to childhood abuse and monkeys raised with social 
deprivation (Heim et al., 2009; Winslow, 2005).  
As for the possible treatment for ASD affected people, different studies have 
examined the effects of OT administered intranasally to high-functioning autistic patients 
(Andari et al., 2010; Guastella et al., 2009; Hollander et al., 2007). While not a cure, the 
results are promising. These initial trials report that, relative to placebo, OT improves eye 
contact, social memory, and use of social information. These reports should be 
considered a proof of principle. With the advent of nonpeptide agonists (Ring et al., 2010) 
and expanded clinical trial infrastructure allowing research with a broader range of 
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children and adults with autism, there may soon be an opportunity to develop new 
pharmacological agents specifically directed to social deﬁcits. 
 
Many of the defining characteristics of autism spectrum disorders such as atypical 
social behaviour, repetitive and stereotypic behavioural patterns, and increased anxiety 
and emotionality are, as expected, affected by AVP. Interestingly, ASD is more prevalent 
in males (Chakrabarti and Fombonne, 2005), likewise the effects of AVP on these 
behaviours are most pronounced in male animals (Bielsky et al., 2005). There have been 
a few studies of human sibling pairs (1 out of 2 affected) suggesting that the V1aR is an 
autism susceptibility gene (Kim et al., 2002; Wassink et al., 2004; Yirmiya et al., 2006). A 
more powerful approach using more extended families found a signiﬁcant linkage to 
chromosome 112q14 where, among other genes, the V1aR gene is located (Ma et al., 
2007). While the 5‟ ﬂanking region of the V1aR is not thought to cause autism, because 
ASD likely has diverse etiologies (Muller, 2007), it has been proposed that its variation 
could contribute, along with other genetic and environmental factors, to affect the onset 
and severity of the disease (Carter, 2007). 
The microsatellite sequences of the 5‟ ﬂanking region of the V1aR have been 
examined for their inﬂuences on various behaviours. In addition, a very strong linkage to 
creativity in dance was found by Bachner-Melman et al. (2005). These linkage studies, 
taken together, suggest a possible role for these polymorphisms inﬂuencing V1aR‟s role 
in social communication and the interpretation of social context. Also a particular 
polymorphism in the V1bR is associated with reduced susceptibility to recurrent major 
depression (van West et al., 2004). These genetic approaches, coupled with the 
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development of better behavioural animal models, suggest that the in the next future the 
answer to many of the ongoing questions regarding AVP‟s role in behaviour could be 
found. 
 
2.3. Neurohormones and behaviour 
 
2.3.1 Rodent models 
 
2.3.1.1 Social memory and social recognition 
A great body of evidence indicates that both neuropeptides AVP and OT inﬂuence 
social memory. Early work by Dluzen and colleagues indicates that OT inﬂuences social 
recognition responses in males by affecting the ability to process odors. Infusion of OT 
into the ofactory bulb facilitates social recognition at both a 30- and 120-min delay 
compared to vehicle-treated animals, but infusion of the OT antagonist OVTA into the 
same region of the olfactory bulb fails to block social recognition at either time delay 
(Dluzen et al., 1998). OT also facilitates social recognition when administered in other 
regions. Infusion into the lateral ventricles signiﬁcantly enhances social recognition 120 
min later at doses of 1 fg–10 ng/rat when injected after the ﬁrst encounter (Benelli et al., 
1995), indicating a role for OT in the acquisition phase of social memory. Similarly, 
infusion of the OT antagonist d(CH2)5[Tyr(Me) 2–Orn8] vasotocin (CPOVT) 5 min before 
OT injection abolishes the social memory-enhancing effect. Social recognition is 
facilitated by OT injection into the medial preoptic area of the hypothalamus (mPOA) with 
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a wide range of doses (0.3–1000 pg), but not when injected into the septum (Popik and 
van Ree, 1991). Interestingly, AVP facilitates social recognition when injected into the 
septum (Engelmann and Landgraf, 1994), but not in the medial pre-optic area (Popik and 
vanRee, 1991), indicating that these two neuropeptides inﬂuence social recognition in 
different brain regions. Finally, peripheral subcutaneous administration of OT and related 
peptides containing the C-terminal glycinamide has been shown to facilitate social 
recognition at low doses (Popik et al., 1996).  
The development of OT and OT receptor KO mice has led to the further 
characterization of OT‟s role in social recognition responses. Male OT KO mice fail to 
develop social memory on both the habituation–dishabituation test (Lee et al., 2008) and 
the social recognition test (Ferguson et al., 2001). OT in the medial amygdala is 
necessary to facilitate social recognition, as demonstrated by c-fos activation in the 
medial amygdala of wildtype (WT) but not OT KO mice during the initial exposure 
(Ferguson et al., 2001). Interestingly, two independently derived lines of OT KO mice fail 
to show any deﬁcits in general sociability (as measured by the social approach task 
(Crawley et al., 2007), indicating that OT seems to be primarily involved in the memory 
component of social recognition. Recently, though, a similar impairment in social 
recognition in these two lines of OTR KO mice was described. Speciﬁcally, unlike WT 
controls, OTR KO mice continue to investigate a „familiar‟ female as if she were „novel‟ 
(Takayanagi et al., 2005). Furthermore, a line of conditional OTR KO mice to reduce OTR 
expression in parts of the forebrain (OTR FB/FB) was generated. Compared to WT 
littermate controls, OTR FB/FB mice also show social recognition impairment but in a 
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different manner, with decreased investigation of both „familiar‟ and „novel‟ females on the 
second trial (Lee et al., 2008).  
Generation of KO mice has allowed for investigation into the importance of 
proteins that regulate OT secretion. OT release is controlled, in part, by intracellular 
calcium stores (Ludwig and Leng, 2006). CD38 is a transmembrane glycoprotein that, 
through formation of cyclic ADP-ribose and nicotinic acid adenine dinucleotide phosphate, 
mobilizes Ca++ and affects OT secretion. CD38 KO mice show normal synthesis and 
storage of OT in axon terminals, but abnormally low plasma and high hypothalamic OT 
concentrations, indicating abnormal release of OT in these mice, from both axon 
terminals and soma and/or dendrites (Jin et al., 2007). Interestingly, these mice show 
deﬁcits in social recognition similar to those of the OT and OTR KO described above.  
 
There is compelling evidence that AVP is important for social memory formation 
and social recognition. Furthermore, the use of V1aR and V1b KO mice has further 
elucidated the role of AVP in the formation of social memory. In the NIMH line of V1aR 
knockout mice the effects on social recognition have been mixed. Bielsky et al. (2004) 
demonstrated that male V1aR-/- mice have impaired social recognition that can be 
rescued by over-expression of V1aR in the LS. On the other hand, Wersinger et al. 
(2007) found no deﬁcits in social recognition but rather a deﬁcit in olfaction in V1aR-/- 
mice. Whether this discrepancy is due to slightly different strain backgrounds or testing 
procedures is unknown, but it is clear from previous works that AVP within the LS is 
important for social recognition. Interestingly, V1b mice also show mild impairments in 
social recognition (Wersinger et al., 2002). 
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2.3.1.2. Aggression 
Aggressive behaviour occurs in situations of competition (for food, mates or space) 
to establish hierarchy in a social group. Generally, aggression in rodents is believed to be 
heavily under the control of AVP (Caldwell et al., 2008). The role of OT in controlling 
aggressive behaviour in males is ambiguous and depends upon the species used, the 
test animals‟ sexual status and the age at which OT levels are manipulated. In prairie 
voles, ventricular delivery of OT reduces sexual behaviour but has no effect on 
aggression (Mahalati et al., 1991) and it has been shown to affect aggressive behaviour 
after, but not prior to, mating (Winslow et al., 1993b). Interestingly, male Wistar rats 
introduced as an intruder to the cage of a singly housed male rat have between two- and 
ﬁve-fold increases in OT levels in the SON and anterior ventrolateral portion of the 
hypothalamus (Engelmann et al., 1999). This suggests that OT‟s role in aggressive 
encounters may have more to do with the stress response to this type of social interaction 
than aggression per se.  
In male squirrel monkeys pair-housed for a sufficient length of time in which to 
form a stable dominant-subordinate relationship, OT signiﬁcantly increases sexual and 
aggressive behaviours in the dominant, but not subordinate male, during interaction with 
a female. Similarly, the increase in aggression is blocked following concomitant 
administration of OT and the OT antagonist OVTA (Winslow and Insel, 1991). A clear 
picture has yet to emerge from studies using transgenic mice. One line with inactivation of 
the OT gene is mildly less aggressive than WT or heterozygous controls, and shows no 
difference in anxiety behaviour in an open ﬁeld (DeVries et al., 1997). In a different line of 
OT KO mice, other researchers have reported increased aggressive behaviour in the 
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resident-intruder paradigm and decreased anxiety in the elevated plus maze (EPM) 
(Winslow et al., 2000). These effects were noted only in KO mice born from KO–KO 
matings; KO mice, and their WT controls, were cross-fostered to WT mothers. KO‟s 
produced from HET-HET matings show no reduction in anxiety and a small increase in 
aggression only on the third aggressive encounter. This suggests that the effects on 
aggression and anxiety are due to the lack of OT in the prenatal environment, or an 
interaction of genotype and the stress of cross-fostering. Elevated levels of aggression 
are also reported in OTR knockouts generated from non-obligates, consistent with the 
idea that a lack of prenatal activation of the OT system results in increased adult 
aggression (Takayanagi et al., 2005). 
 
Studies of the role of AVP in the regulation of aggression have mostly focused on 
offensive aggression, which in rodents is examined using a resident-intruder test. 
Two important concepts have emerged so far: AVP primarily modulates intermale 
aggression and AVP-facilitated aggression appears to be dependent upon prior 
experience, suggesting the presence of synaptic learning and-or epigenetic regulation of 
gene expression. Also, while key anatomical sites have been identiﬁed, their interactions 
with one other, as well as the interactions of AVP with other neurotransmitter systems are 
still poorly understood. The vasopressinergic projections from the BNST and MeA to the 
caudal LS are important for aggression and are androgen-dependent (De Vries and 
Miller, 1998). The anterior hypothalamus (AH) is also consistently implicated in the 
regulation of aggression and V1aR in this area demonstrates considerable plasticity 
(Askew et al., 2006).  
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2.3.1.3. Learning and memory 
Memory processes are highly inﬂuenced by neuropeptides. Generally, AVP seems 
to enhance both non-spatial and spatial memory, likely through connections between the 
hippocampus and septum (Caldwell et al. 2008). In contrast, OT seems to attenuate 
memory processes. Recently, de Oliveria and colleagues also showed that i.p. OT 
administered prior to testing impairs inhibitory avoidance measuring „step-down latency 
without causing increases in anxiety alone (tested on EPM) with an accompanying 
decrease in corticosterone levels (de Oliveira et al., 2007). Stress hormones and effects 
on the hypothalamic–pituitary–adrenal (HPA) axis may therefore mediate the amnesic 
effects of OT. The site of injection can also affect OT-induced changes in memory. 
Passive avoidance behaviour is impaired with post-learning injections of OT in either the 
dentate gyrus or dorsal raphe nucleus; however, memory is facilitated with OT injection 
into the dorsal septal nucleus (Kovacs et al., 1979). Furthermore, OT antiserum injected 
into dorsal hippocampus, dorsal raphe nucleus, or lateral habenula does not impair 
passive avoidance (Greidanus and Baars, 1993), contradicting the idea that OT is 
generally an amnesic peptide. Whether OT inﬂuences spatial memory is unclear. OTR 
are highly expressed in the hippocampus of mice (Insel et al., 1991). Hippocampal slices 
treated with OT in vitro maintain long-term potentiation (LTP) signiﬁcantly longer than 
untreated slices, and have higher levels of phosphorylated CREB (Tomizawa et al., 
2003). In other brain regions, OT also appears to inhibit spatial memory. Injections of OT 
into the nucleus basalis of Meynert (NBM), a region that provides primary cholinergic 
pathways to the cortex and is involved attention and memory (Wenk, 1997), signiﬁcantly 
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increases latency to escape onto the hidden platform in the Morris water maze. 
Furthermore, injection of the OT antagonist atosiban into the NBM blocks the OT induced 
impairment, indicating that action at the OTR in the NBM is responsible for inhibition of 
spatial memory (Wu and Yu, 2004). Interestingly, mice lacking the OT gene throughout 
the brain and body do not show deﬁcits on the Morris or Y-maze, indicating that OT is not 
necessary for spatial memory (Ferguson et al., 2000). 
 
In addition to its effects on social memory and interactions, de Wied in the 1960s 
ﬁrmly established a modulatory effect of hypothalamic AVP on non-social learning and 
memory: he found that removal of the posterior pituitary impaired active avoidance shuttle 
box performance in rats (de Wied, 1965) that could be improved with AVP administration 
(Bohus et al., 1972). Since then, AVP has repeatedly been shown to affect non-spatial 
and spatial memory, with most studies ﬁnding an enhancing effect on memory, most likely 
through inﬂuences on the hippocampal-septal interactions (Croiset et al., 2000;). AVP can 
enhance consolidation of memories, but seems more important in memory retrieval 
(Gulpinar and Yegen, 2004). In passive avoidance, both administration of AVP 
immediately after the last learning trial or just prior to the retention trial improves learning 
(Kovacs et al., 1986). 
More recently, subcutaneous administration of NC-1900, an AVP analog with a 
longer half-life, was shown to ameliorate deﬁcits in passive avoidance memory produced 
by inhibition of the COX-2 pathway (Sato et al., 2007), indicating that AVP may affect 
memory through this pathway. As for spatial memory, performance in the radial arm maze 
is enhanced by AVP, as administration signiﬁcantly enhances learned extinction 
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behaviour, that is learning that food was no longer present in the arms (Packard and 
Ettenberg, 1985). Scopolamine, an anticholinergic, produces deﬁcits in reference and 
working memory in the radial arm maze. These memory deﬁcits are reversed with 
administration of AVP (Taga et al., 2001) and NC-1900 (Mishima et al., 2003). Moreover, 
V1aR KO mice have impaired working memory in the radial arm maze as compared to 
controls (Egashira et al., 2006), indicating a role for the V1aR receptor in spatial task 
performance. Conversely, V1b KO mice do not have impaired spatial memory on the 
Morris water maze (Wersinger et al., 2002; Egashira et al., 2004). 
 
2.3.1.4. Emotional behaviour 
Oxytocin is thought to work as an anxiolytic as it decreases release of stress 
hormones in both humans (Legros, 2001) and rats (Stachowiak et al.1995). Endogenous 
release of OT in males during mating can reduce anxiety-like behaviours (Waldherr and 
Neumann, 2007). In male rats, OT administration reduces anxiety-like behaviours in a 
number of behavioural tests; in mice, this effect is blocked in some tests by the OT 
antagonist WAY-162720 (Ring et al., 2006). The anxiolytic properties of OT may be 
mediated, at least in part, via action at the OTR in the amygdala which is well known for 
its role in the acquisition, modulation and storage of emotional memory (LeDoux, 2007). 
OT infusion into the amygdala has an anxiolytic effect on ovariectomized female rats in 
an open ﬁeld (Bale et al., 2001). Projections from the septum and the amygdala may 
modulate the hypothalamic-pituitary-adrenal axis via connections to OT neurons in the 
PVN and SON (Oldﬁeld et al., 1985). Within the extended amygdala there are many 
regions with binding sites for OT (Veinante and Freund- Mercier, 1997). In one line of OT 
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KO mice, male offspring of KO–KO parents show reduced anxiety on the elevated plus 
maze, though this effect may be due to lack of exposure to OT in utero (Winslow et al., 
2000). It has also been shown that there is no effect on anxiety-like behaviour in OTR KO 
mice or in a partial forebrain-speciﬁc OTR knockout line (Lee et al., 2008).  
 
High densities of vasopressinergic ﬁbers (De Vries and Buijs, 1983) and V1aR 
(Ostrowski et al., 1992) are found within the septum. Anxiety-related behaviour, as 
measured on the elevated plus maze (EPM), is signiﬁcantly reduced with septal infusion 
of antisense oligodeoxynucleotide to the V1aR mRNA (Landgraf et al., 1995), as well as 
with the V1aR antagonist d(Ch2)5Tyr(Me)AVP (Engelmann et al., 2000), in the absence 
of altered locomotor activity. However, Appenrodt et al. (1998) found both intraseptal and 
intraperitoneal (i.p.) application of AVP is also anxiolytic, indicating possible actions 
outside of the septum. Moreover, some transgenic mice studies indicate a role for V1aR 
in modulating anxiety. V1aR KO males display signiﬁcantly less anxiety-related behaviour 
than wildtype males on a variety of tasks (Egashira et al., 2007). Additionally, over-
expression of the V1aR gene in the LS signiﬁcantly increases anxiety-related behaviour 
(Bielsky et al., 2005), further implicating V1aR in controlling the anxiety response. 
However, in another lab, no anxiolytic phenotype has been found in this line (Caldwell et 
al., 2006). Ample evidence indicates that, in addition to affecting anxiety-related 
behaviour, AVP affects depression-related behaviour. In rodents, the forced swim task 
produces immobility that can be reversed with antidepressants (Porsolt et al., 1977). 
Acute forced swimming induces a signiﬁcant increase in AVP release in both the SON 
and PVN that increases further in the PVN with repeated swimming (Wotjak et al., 1998). 
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Applications of the V1aR antagonist d(Ch2)5Tyr(Me)AVP into both the mediolateral 
septum and the amygdala have antidepressant-like effects (Ebner et al., 1999, 2002). 
Antidepressant-like effects are also observed with oral and intraperitoneal (i.p.) 
administration of the V1b antagonist SSR149415, even after hypophysectomy (Griebel et 
al., 2002). Infusion of SSR149415 into the LS and into three nuclei of the amygdala also 
decreases immobility time in the forced swim task (Salome et al., 2006). However, 
wildtype, V1aR -/- and V1bR -/- mice do not differ in this swimming behaviour (Egashira et 
al., 2007). 
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2.3.2. The Zebrafish model 
 
2.3.2.1. General description and behavioral models 
Zebrafish, Danio rerio, is one of the most important vertebrate model organisms in 
genetics, developmental biology, neurophysiology and biomedicine (Amsterdam and 
Hopkins, 2006). It has a number of attributes that make it particularly useful for 
experimental manipulation. It is a small, robust fish and large numbers of individuals can 
be kept easily and cheaply in the lab, where it breeds all year round. Females can spawn 
every 2-3 days and a single clutch may contain several hundred eggs. Generation time is 
short, typically 3-4 months, making it suitable for selection experiments. Furthermore, 
fertilisation is external so live embryos are accessible to manipulation and can be 
monitored through all developmental stages under a dissecting microscope (Kimmel et 
al., 1995). Zebrafish embryos and early adults are optically transparent, a characteristic 
that facilitates direct observation of internal organs by light microscopy; during 
organogenesis, embryos are permeable to small molecules and drugs, providing easy 
access for drug administration and vital dye staining. Expression of specific proteins can 
be suppressed throughout the developing embryo using of morpholino antisense 
oligodeoxynucleotides; this enables monitoring the roles of specific proteins in 
development and/or drug response. Conversely, embryos can be microinjected with 
either capped mRNA or plasmids to express specific proteins and variants (including 
splice variants, point mutants, etc.), either throughout the embryo or in a tissue-specific 
manner. In combination with morpholino antisense oligodeoxynucleotides, this approach 
resembles „„knock-out/knock-in‟‟ approaches widely used in mice. Zebrafish genome has 
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been sequenced and can be accessed at UCSC genome browser (Kari et al., 2007). In 
fact the greatest advantages of the zebrafish as a model system come from its well-
characterised genetics, genetic and developmental techniques and tools and the 
availability of well-characterised mutants. Its nervous system is more comparable to that 
of humans than Drosophila. Zebrafish are also tractable species for behavioural 
experiments, readily acclimatising to new environments, being constantly active and little 
disturbed by the presence of observers. In order for the zebrafish to be more widely 
adopted as a model by the behavioural ecology community there is a need for more 
behavioural and field-based studies in order to catalogue natural variation in 
morphological, physiological and behavioural traits.  
 
Zebrafish appears ideally suited to studies of social and cognitive behaviour and it 
is surprising that it has been so little utilised for this purpose. There is increasing interest 
in employing social and cognitive tests with zebrafish to study the genetic basis of 
behaviour and there is a need for more comprehensive and better controlled studies in 
this area (Spence et al., 2008). What it is known is that in zebrafish the preference for 
associating with other fish is innate while the preference for particular colour patterns is 
based on learned behaviour. Individuals raised in isolation do not display colour pattern 
preferences whereas cross-reared individuals prefer to associate with the colour pattern 
with which they were raised (Engeszer et al., 2004; Spence et al, 2008). Learned 
preferences are mediated by olfactory as well as visual cues; zebrafish can differentiate 
between familiar and unfamiliar conspecifics on the basis of odour and thus appear 
capable of individual recognition (Gerlach and Lysiak, 2006). The response shown by 
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zebrafish to alarm substance is also innate but appears to function as a means of learned 
predator recognition. Alarm substance can initiate a conditioned response to an 
innocuous odour, such as morpholine, when the two are presented simultaneously 
(Suboski et al., 1993). Hall and Suboski (1995) further elicited a learned response to a 
visual cue by pairing alarm substance with a red light as well as with morpholine. Thus, 
conditioning can operate across different sensory modalities. The same authors also 
demonstrated second-order conditioning whereby fish conditioned with alarm substance 
to respond to either light or morpholine then learned to react to the second neutral 
stimulus when presented in combination with the first conditioned stimulus in the absence 
of alarm substance. An alternative approach to studying learning is to use an operant 
conditioning paradigm, whereby fish are trained to swim in a specific direction for a food 
reward paired with a visual cue. This approach has been used to study spatial memory, 
landmark use and orientation in other species (Braithwaite et al., 1998), and the few 
studies available indicate that zebrafish are potentially a useful model for research in this 
area. In a study to investigate spatial learning and memory, Williams, White and Messer 
(2002) trained adult zebrafish to swim alternately to one or other side of a divided 
aquarium to receive a food reward. Once trained, the fish could remember the task after a 
10-day period during which they were fed ad libitum in another aquarium. Zebrafish was 
also able to learn to swim into one of three compartments when the one containing the 
reward was cued by a white light (Bilotta et al., 2005). A three-choice design provides 
better evidence of learning than a two-choice design as the level of a chance response is 
reduced to one-third. Different tasks have been shown to elicit different preferences. 
Colwill et al. (2005) used a T maze with different-coloured arms (green versus purple or 
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red versus blue) to assess visual discrimination learning in zebrafish. They found that 
while fish could be trained to swim down whichever coloured arm was associated with a 
food reward, they learned faster and retained the response longer when the colour 
associated with the reward was purple or blue than when it was green or red. Thus, not 
only were the stimuli not perceived as equal, but the colour preferences shown in this 
context differed from those in the foraging study by Spence and Smith (2007).  
Furthermore zebrafish model has been validated for studying the process of 
addiction in vertebrates, for example using the CPP test with cocaine (Darland and 
Dowling, 2001) and amphetamine (Ninkovic et al., 2006). Moreover, ethanol-induced 
hyperlocomotion can be blocked by the addition of a dopamine antagonist, suggesting the 
involvement of the brain dopamine system (Lockwood et al., 2004).  
 
2.3.2.2. The social zebrafish 
Zebrafish is a highly social species that prefers swimming in groups, an 
aggregation behaviour termed shoaling (Pitcher, 1983) and described in a number of fish 
species (Wright et al., 2006). Other traditional laboratory organisms including the mouse 
and the rat, or simpler organisms such as Drosophila or the nematode, do not exhibit the 
degree of social cohesion and group preference displayed by zebrafish. Thus, in addition 
to the genetic tools developed for zebrafish, its behavioural characteristics make this 
species particularly appropriate for this kind of studies. It has to be noted that the 
mechanisms of social behaviour of vertebrates including our own species are not clearly 
understood and as a result diseases associated with abnormal social behaviours in 
humans (including social phobias and autism spectrum disorders) have been difficult to 
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treat. Given the high nucleotide and amino acid sequence homologies found at the DNA 
and protein levels between zebrafish and mammals including humans (Barut and Zon, 
2000) and the similarities of the basic layout of the brain of these species, it is not unlikely 
that the analysis of genetic mechanisms of social behaviour of zebrafish will lead to 
results that generalize and translate to other vertebrate species including our own 
(Tropepe and Sive, 2003). Preference of zebrafish for certain stimulus fish was 
investigated in choice paradigms (Engeszer et al., 2004). Results demonstrated that 
zebrafish were sensitive to certain visual characteristics of the stimulus fish and the 
preference was strongly influenced by early experience during development. 
 
2.3.2.3. Zebrafish and autism 
Studies regarding autism spectrum disorders have recently taken advantage of the 
zebrafish model. Aberrant social behaviour, the most typical characteristic of the disorder, 
can be easily modelled in zebrafish by evaluating different parameters such as the 
tendency to join a shoal, social isolation, the distance from a predator (Dadda et al., 
2010), inhibitory avoidance (Blank et al., 2009), social interaction (Delaney et al., 2002), 
dominance-subordination relationships (Larson et al., 2006), repetitive and stereotyped 
movements (López-Patiño et al., 2008), aggressive behaviour (Colman et al., 2009). 
In humans, about 1% of ASD cases is associated to deletions involving chromosome 16, 
which contains 25 genes that are homologous to zebrafish (Eichler & Zimmerman, 2008). 
The extensive use of morpholino anti-sense oligos to inhibit mRNA maturation of specific 
genes (Nasevicius & Ekker, 2000) made it possible to identify genes involved in neuronal 
and brain development in zebrafish. Very recently, the use of morpholino knock out 
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zebrafish has helped in demonstrating an important role of the so-called Sushi domain, 
consisting in 4 SUDS4 proteins, which results deleted in a group of affected ASD 
patients. In fact, SUDS4 is highly expressed in CNS of different species, such as humans, 
mice and zebrafish in particular, where it plays an essential role in its development. (Tu et 
al., 2010).  
These and other pioneering studies suggest how zebrafish can also be used as a model 
for future sperimentations in order to characterize cellular and molecular mechanisms of 
ASD. 
 
In conclusion, in the near future, zebrafish behavioural quantiﬁcation methods will most 
probably be a great tool for developing automated and high throughput paradigms with 
which the biological mechanisms of different kind of zebraﬁsh behaviour will be 
investigated, a goal that will ultimately lead to better understanding of the genetics of 
complex behaviours in other vertebrates including humans. 
 
 
 
42 
 
Aim of the study 
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Autism is a neurodevelopmental disorder which is characterized by severe and pervasive 
impairment in reciprocal socialization, qualitative impairment in communication and 
repetitive or stereotyped behaviour associated to resistance to change. Oxytocin (OT) is a 
peptidic hormone best known for its role in lactation and parturition. Recently, it has been 
also shown by several studies involving different lines of KO mice to play an important 
role in the CNS by acting on the regulation of social, emotional, aggressive behaviour and 
on learning and memory. Furthermore, prosocial effects following OT administration in 
humans have been shown. The link between OT and autism has already been traced in 
preliminary clinical studies as autism affected patients have received a beneficial 
outcome from treatment with OT. Pharmacokinetic (very short half-life), 
pharmacodynamic properties (unspecific binding to vasopressin receptors) and the 
presence of peripheral side effects of OT, though, make this peptide an unsuitable target 
for a future clinical use. It is important, in this perspective, to characterize specific animal 
models in order to validate the use of OT analogs with more suitable characteristics in 
preclinical research. 
On this purpose our aim will be to characterize more specifically a pre-existing 
mice model lacking the OT receptor in both its heterozygous and homozygous form. 
General health (fur, pilo-erection, body tone, skin colour), reflexes (righting, corneal, 
pinna, tail pinch) and sensory abilities (vision, hearing, smell and pain) will be firstly 
investigated. Motor function will be analyzed through a motor activity cage for 
spontaneous motor activity, rotarod for motor coordination, hanging wire for muscle 
strength. Emotional reactivity will be evaluated in the elevated plus maze for anxiety-like 
behaviour and in the forced swim and tail suspension test for depressive symptoms. 
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Finally, mice will be tested for the core symptoms of autistic disorders: aberrant social 
behaviour in the sociability and social novelty test, aggression in the neutral cage test and 
resistance to change in the T maze task. The effect of OT, AVP and V1aR antagonist 
SR49059 treatment (0.5 ng/mouse i.c.v) will also be investigated in these tasks in order to 
analyze the mechanism through which these altered behaviours take place. 
For an additional characterization of the model, OTR and V1AR receptor binding 
will be evaluated in different brain areas already known to be associated with social and 
cognitive impairments such as anterior olfactory nucleus, vertical limb of the diagonal 
band, pyriform cortex, lateral septum, ventral pallidum, hypothalamus, amygdala, 
hippocampus and supraoptic nucleus.  
Finally, as an increasing interest in the use of zebrafish for social and cognitive 
behavioural analyses to study the genetic basis of behaviour is rising, we will evaluate its 
potential as a screening tool for neuropsychiatric diseases involving deficits in social 
behaviour. In order to do so, we will perform dose-response studies to analyze the effect 
of OT, AVP but most importantly isotocin (ISO) and vasotocin (AVT) (zebrafish 
homologues of OT and AVP, respectively) using the shoaling preference test as social 
paradigm. 
45 
 
Materials & Methods 
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4.1. OTR mutant mice model  
4.1.1. Animals 
The OTR+/+, OTR+/- and OTR-/- mice were obtained from L. Young (USA). All mice 
used were littermates from mated heterozygous and were genotyped by PCR. Mice were 
initially tested for general health, followed by reflexes, sensory, motor and emotional-like 
reactivity and then for behavioural tasks relevant to autism (sociability and social novelty, 
aggression, T maze and seizure susceptibility). For sociability and social novelty and 
neutral cage tests, stranger adult male mice were used, belonging to the DBA/2J strain 
(Charles River, Calco, Italy) chosen for their very low scores of native aggression 
(Crawley, 1997). 
 
4.1.1.1. Maintenance of mice 
 Male mice were individually housed in an air-conditioned room (22 ± 1 °C) with a 
12-h day-dark cycle (lights on: 08:00 hours) and had free access to food and water. Then, 
they were randomly assigned to each experimental group (10 naive animals per group for 
behavioural tasks, 3 animals per group in the autoradiographic binding assay) and tested 
at 3 month of age. All testing took place during the first half of the light period (between 
09:00 and 13:00 hours). Water was always available while food was provided ad libitum 
except during T maze experiments which were conducted under dietary restriction. All the 
experimental procedures followed the guidelines established by the Italian Council on 
Animal Care and were approved by the Italian Government decree No. 37/2007. All 
efforts were made to minimize the number of subjects used and their suffering.  
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4.1.1.2. Genotyping  
Mice were genotyped by PCR using specific primers on DNA extracted from tail 
snips. A single forward primer (N248-5‟CTGGGGCTCAGTCTTGGAAG), and two reverse 
primers (N2475‟GTTGGGAACAGCGGTGATTA;WT25‟CCTCGATACTCCAGTTGGCTG) 
were used for amplification. The PCR was carried out for 35 cycles with denaturation at 
98 °C for 30 sec, annealing at 55 °C for 45 sec, and extension at 72 °C for 1 min. OTR+/+ 
and OTR-/- mice were identified by the presence of either a 700bp or a 450bp specific 
product; OTR+/- mice were identified by the presence of the two products.  
 
4.1.1.4. Surgery 
 Mice were anaesthetized with chloral hydrate (Sigma-Aldrich, Chemicals, Co, MO, 
USA), (450 mg/kg, i.p.). A steel guide cannula (24 gauge) anchored to a acrylic pedestal 
(Greto, Italia) was stereotaxically implanted as per the coordinates referred from Franklin 
and Paxinos (2007)(AP -0.82mm; ML +1.5 mm; and DV +3.0 mm; related to bregma). 
The guide cannula was secured to skull using a mounting screw (Plastic One Inc.,USA) 
and dental cement (Palavit, New Galetti Rossi, Milan, Italy). Each mice was allowed to 
recover for 1 week under antimicrobial cover (Ceftriaxone, Sigma-Aldrich, Chemicals, Co, 
MO,USA, 50 mg/kg i.p.). To ascertain the accuracy of the ICV injections, at the end of the 
experiments, mice were injected by the same route with 2 l of a saturated solution of 
Evans blue (Merck, Whitehouse Station New Jersey) using a Hamilton syringe (Hamilton, 
Nevada, USA) and killed immediately. Macroscopic examination of the brain confirmed 
that only the area around the lateral ventricles was stained. 
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4.1.2. Behavioural Assays 
 
4.1.2.1. General health and reflexes 
Each mouse was observed and any abnormalities in the general appearance of 
the fur (3-point scale), pilo-erection, body tone (3-point scale), skin colour were recorded 
according to Lee et al. (2008). Furthermore, mice were observed for the empty cage 
behaviour (nest-building behaviour) according to Deacon (2006) using a 5-point scale. 
Neurological reflexes were assessed, including righting reflex (4-point-scale) 
corneal (8-point scale), pinna (8-point scale) and tail pinch (8-point scale) according to 
Irwin (1968). 
 
4.1.2.2. Sensory abilities 
 Hearing was evaluated using Preyer‟s reflex testing through a 
handclap sound. The reflex was considered positive (and scored 1 in 0-1 point 
scale) when a rapid movement of the whole body of the animal was clearly noticed 
as previously described (Jero et al., 2001).  
 Visual acuity was performed according to Brandewiede et al. (2005) 
using the visual cliff test. The apparatus consisted of a plexiglass box (60x40x61 
cm). A platform was installed adjacent to a wall 32 cm above the floor of the box. 
The platform and the inner surface of the box were covered with black and white 
checkboarded contact paper that emphasised the ledge drop-off. A piece of clear 
Plexiglas covered the platform and spanned the ledge so that there was no actual 
drop-off but only the visual appearance of the cliff. Mice were placed on the 
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platform close to the wall. Mice that spent a significantly higher amount of time on 
the checkboarded platform rather than in the transparent one were considered to 
have good sight.  
 Olfactory test was carried out according to Moy et al. (2004). Two 
days before the test, an unfamiliar palatable food (Kellogg‟s chocolate cereal) was 
placed overnight in the home cage of the subject mice. On the day of the test, 
each mouse was placed in a large cage containing 3 cm deep sawdust and 
allowed to explore for 5 minutes. The animal was removed from the cage, and one 
cereal was buried in the cage bedding. The animal was then returned to the cage 
and given 15 minutes to locate the buried food. Latency to find the cereal was 
recorded.  
 Pain sensitivity. The hot-plate assay was performed at 52°C. The 
time (s) elapsing to the first pain response (licking or jumping) was recorded. A 
maximal latency of 40 s was used (Crawley, 2000).  
 
4.1.2.3. Motor functions 
 Spontaneous motor activity was evaluated in an activity cage (41 X 
41 X 32 cm) (Ugo Basile, Varese, Italy), placed in a sound-attenuating room 
(Braida and Sala, 2000). The cage was fitted with two parallel horizontal and 
vertical infrared beams located 0 cm from the floor. Cumulative horizontal and 
vertical movement counts were recorded for 30 min.  
 Motor coordination and balance were evaluated during four 
consecutive 120 s trials by quantifying the ability to maintain balance on a rotating 
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cylinder using the rotarod test as described by Daugé et al. (2001). The latency to 
fall from the rotarod was recorded 
 Muscle strength was measured using the hanging wire cage test. 
Mice were placed on the underside of a standard wire rat cage top approximately 
20 cm above a large cage containing soft sawdust bedding. The latency to release 
was recorded, with a maximum latency of 300s (Crawley, 2000). 
 
4.1.2.4. Emotional like reactivity 
 Anxiety was measured according to Lister (1987) in an Elevated Plus 
Maze. Each animal was placed onto the centre of the apparatus and the time 
spent on and entries onto each arm were registered for 5 min. The percentage of 
time spent in the open arms and the percentage of open-arm entries id used as 
measure of anxiety.  
 Forced swim (FST) and tail suspension (TST) tests were used to 
assess the depressive phenotype. FST (Porsolt et al., 1977) consisted in forcing 
mice to swim for 6 min under conditions in which escape is not possible. Time 
spent immobile (sec) was measured in the last 4 minutes of the test only, 
considering the first 2 minutes as an habituation phase. TST is based on the 
observation that a mouse suspended by the tail alternates periods of complete 
immobility and agitation. The test was conducted according to the procedure of 
Steru et al., (1985). Mice were held by the tail suspended dangling in the air at 35 
cm from the floor for 5 min. The duration of immobility (sec) was measured.  
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4.1.2.5. Core symptoms of autism 
 Sociability and preference for social novelty test: the sociability and preference 
for social novelty test was used as described by Moy et al. (2007), with slight 
modifications. The apparatus consisted in a three equal and communicating 
transparent Plexiglas chambers (41 X 41 X 32 cm). The test procedure consisted 
in three separated phases. Habituation: the test mouse was placed in the middle 
chamber and allowed to explore the whole apparatus for 10 minutes. Each of the 
two outermost sides contained an empty wire cage. Sociability: after the 
habituation period, the test mouse was enclosed in the centre compartment of the 
box, and an unfamiliar male mouse (stranger 1, a never-seen-before adult male 
DBA/2J mouse) was enclosed in one of the wire cages and placed in one of the 
side chambers. The location of stranger 1 alternated between the left and right 
sides of the box across subjects. Following placement of stranger 1, the doors 
were re-opened and the subject was allowed to explore the apparatus for 10 min. 
The time spent in each chamber and the number of entries made in each 
chamber was recorded. The difference score for sociability was calculated as 
difference between the time spent in the compartments containing the familiar 
littermate and the time spent in the empty compartment according to DeVito et al., 
(2009). Preference for social novelty: at the end of the sociability test, each 
mouse was tested in a further 10-min session to quantify preference to spend 
time with a new stranger. A new unfamiliar mouse (adult male DBA/2J mouse) 
was placed in the wire cage that had been empty in the previous phases. The test 
mouse had to choose between spending time in the proximity of the first, already-
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investigated, familiar mouse (stranger 1) and the novel unfamiliar mouse (stranger 
2). The time spent in each chamber and the number of entries made in each 
chamber was recorded, as described above. The difference score for social 
novelty was calculated as difference between the investigation times for the 
compartments containing the novel animal and that for the familiar littermate 
according to DeVito et al., (2009).  
 Aggression: the test was performed according to Tordjman et al. 
(2003) in a neutral area (a transparent cage with dust-free clean sawdust). The 
tested male was placed in the neutral cage and followed 10 min later by the 
opponent, a never-seen-before DBA/2J male adult mouse. The test lasted 6 min 
during which we measured attack latency (the time elapsing between the first 
sniffing until the first attack) and the number of attacks. 
 T maze: the task was conducted according to Moy et al. (2007). 
Before starting, animals were food deprived to 85-90% of their free-feeding body 
weight. Mice were then habituated to a black T- maze and shaped to obtain food 
across the maze for 5 days. In the first acquisition phase, for each mouse one arm 
was designated as the correct arm where one palatable food reward (Kellogg‟s 
chocolate rice cereal) was available for each trial. The reinforced arm was on the 
left side for half of the mice, and on the right side for the other half. At the 
beginning of each session, each mouse was placed at the start of the maze and 
was then given a choice between entering either arm. If the mouse made the 
correct choice, it was given time to consume the pellet and then guided back to the 
start for the next 9 daily trials. Incorrect choices were not rewarded or punished. 
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For each successive trial the reward was always placed in the same arm. The 
criterion was reached when the mouse made 80% of correct choices for three 
consecutive days. The number of days taken to reach the criterion was recorded. 
Each mouse that met criterion for acquisition was the tested using a reversal 
procedure, in which the reinforce location was switched to the arm opposite to its 
previous location. Ten trials per day were administered for reversal learning, using 
the same methods and criterion as described above. 
 
4.1.3. Autoradiography binding studies 
(in collaboration with prof. Daniela Parolaro, Università dell’Insubria, Italy) 
Brains were rapidly removed, frozen in liquid nitrogen and stored at -80°C until 
processing. Twenty-micron coronal sections were cut with a cryostat, thaw-
mounted on gelatin-coated slides and processed following Francis et al., 2002. 
Specific and non specific binding were determined by incubating adjacent sections 
with the specific 125I-OVTA (Elands et al., 1988) (NEX254, 2200 Ci/mmol, Perkin 
Elmer, Boston, MA, USA) and [125I] Linear AVPA (NEX310, 2200 Ci/mmol, Perkin 
Elmer, Boston, MA, USA) ligands at final concentrations of 50 pM with or without 
50 pM unlabelled Thr4Gly7OT, a selective OT ligand (Peninsula Laboratories, 
Belmont, CA, USA), or 50 pM of unlabelled Linear AVPA, a selective V1aRR 
antagonist (Schmidt et al., 1991). Autoradiographic 125I receptor binding was 
quantified as in Rubino et al., 2005. The intensity of the autoradiographic film was 
assessed by measuring the grey levels with an image analysis system provided by 
54 
 
Immagini & Computer (Milan, Italy) consisting of a dual scanner Artixscan 1800F 
connected to a personal computer (PC). The software IMAGE-PRO PLUS version 
5.0 (Media Cybernetics Inc., Silver Spring, MD, USA) was used. Each cerebral 
area was traced with the mouse cursor control and the light transmittance was 
determined as the grey level. The grey level of densitometric measurements 
calculated after subtracting the film background density was established within the 
linear range determined using tritium standards (3H Microscales, Amersham 
Pharmacia Biotech, Milan, Italy) for receptor binding studies made in the laboratory 
for [35S]GTPγS binding studies. 
  
3.1.4. Drugs and Treatments 
Oxytocin (OT) and vasopressin (AVP) (Bachem, Germany, EU) were dissolved in 
artificial cephalorachidian liquid (aCSF) and given intracerebroventricularly (ICV) 
10 min before each test. In particular for the T maze task treatments were 
performed before each daily trial in the reversal phase only. The selective V1aR 
antagonist, SR49059 (Sanofi-Aventis, Paris, France) was dissolved in aCSF and 
given ICV at a dose of 0.5 ng/2 l/mouse 20 minutes before each test. OT and AVP 
were given at a dose of 0.5 ng/2 l/mouse since a previous study (Meisenberg and 
Simmons, 1987) demonstrated grooming behaviour, starting from 1 ng/mouse. 
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4.1.5. Statistical Analysis 
All measurements were compared between genotypes using a one- or two-way 
repeated measures ANOVA test where appropriate, followed by Tukey‟s, 
Bonferroni or Dunn‟s tests. Data expressed as percentage were analyzed with 
Fisher exact probability test. The accepted level of significance was p<0.05. All 
statistical analyses were done with software Prism, version 5 (GraphPad, San 
Diego, California). 
 
4.2. Zebrafish model 
4.2.1. Subjects 
Adult AB wild type (WT) zebrafish (D. rerio) (50% male and 50% female) and were 
purchased from a local pet shop (Aquarium Center, Milan, Italy). Nacre mutant 
zebrafish were a kind gift of Dr Mione (IFOM-IEO, Milan, Italy). Both strains were 
kept at approximately 28.5°C on a 14-h light/10-h dark cycle. All fish were raised 
with their wild-type siblings in visual isolation from other phenotypes. Behavioural 
testing took place during the light phase between 9.00 and 14.00 hours. Tank 
water consisted of deionized H2O and sea salts (0.6 g/10 l of water; Instant Ocean, 
Aquarium Systems, Sarrebourg, France). The home tanks with groups of 
approximately 30 adult fish were maintained with constant filtration and aeration. 
Fish were fed daily with brine shrimp and flake fish food (Tropical fish food, 
Consorzio G5, Italy). All the fish were drug naive and each fish was used only 
once. 10 fish per group were used. The experimental protocol was approved by 
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the Italian Governmental Decree No. 14/07. All efforts were made to minimize the 
number of animals used and their discomfort. 
 
4.2.2. Behavioural assays 
 
4.2.2.1. Shoaling preference test 
Shoaling preference test was carried out according to Engeszer et al. (2008). 
Nacre mutants and WT counterparts were used as stimulus fish shoals. All 
stimulus shoals comprised two males and two females randomly chosen from each 
group tank. Shoals of as few as four zebrafish exhibit shoaling behaviours 
indistinguishable from those of larger groups (Breder, 1959). A glass test tank (122 
cm long x 55 cm tall x 32 cm wide) divided into five equal compartments, was 
used. Outermost compartments, hereafter referred to as stimulus areas, were 
separated from inner compartments by glass walls, which were sealed with silicon 
aquarium sealant to isolate water in the stimulus areas from the inner 
compartment. We further subdivided the inner compartment, marking off three 
zones of equal volume comprising a left preference area, a central no-preference 
area, and a right preference area. The tank was lit by two 250-W halogen lamps 
placed above and on either side of the test tank. Light from these lamps then 
reflected off two sheets of Teflon hung at a 45° angle from the top of the tank. Thin 
sheets of opaque plastic, as temporary visual barriers to separate the exterior 
compartments from the interior compartment, were used. The water level in the 
tank was kept at 25 cm depth. Opaque barriers were placed in the central 
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compartment, to visually isolate the subject fish from the stimulus areas, one 
containing the stimulus (nacre) shoal, the other the WT shoal. Immediately after 
treatment, the subject fish was placed in the central compartment. The fish were 
allowed 5 min to acclimate to the test tank. Then the opaque barriers were 
removed and started recording shoaling behaviour by using Canon Digital MV900 
compact camera. Fish were allowed up to 15 min to recognize both stimuli. We 
started recording time spent in association with each stimulus after the first 5-min 
period in which the subject recognized both stimuli. If the subject did not recognize 
both stimuli in 15 min, the test was cancelled and redone at the beginning of the 
following week. When the fish subject swam parallel to one of the shoal members, 
it was considered to recognize the stimulus shoal. (Engeszer et al., 2004). 
Shoaling preference was quantified by recording the total time spent by the WT 
test fish in proximity of each stimulus shoal. 
   
  4.2.3 Drugs and treatment 
Body weight was measured as previously described (Braida et al., 2007). Briefly, 
fish were removed from their tank using a net and placed in a container containing 
tank water, positioned on a digital balance. Fish weight was determined as the 
weight of the container plus the fish minus the weight of the container before the 
fish was added. The mean of three measurements was recorded. Fish were 
injected intramuscularly (i.m.) in the caudal musculature using a volume depending 
on the weight of the fish (2 μl/g) using a Hamilton syringe (Hamilton Bonaduz AG, 
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Bonaduz, Switzerland). Oxytocin, vasopressin ((Arg8)-Vasopressin), isotocin 
((Ser4,Ile8)-Oxytocin) and vasotocin ((Arg8)-Vasotocin) (Bachem, Germany) were 
disolved in saline (0.9%). All drugs were prepared fresh daily. 
 
4.2.4 Statistical analysis 
 
All data are expressed as mean±sem. For the dose-response analysis of the 
different peptides, data were analyzed against the log of the administered doses; 
the values of the social parameter considered were calculated by the statistical 
analysis adapted to curvilinear regressions according to Steel and Torrie (1960). 
All statistical analyses were done using software Prism, version 5 (GraphPad, San 
Diego, CA, USA). The accepted level of significance was P<0.05. 
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Results 
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5.1 OTR mutant mice  
 
5.1.1. OTR mutant mice phenotypical characterization 
 
5. 1.1.1 General phenotypic and sensory characteristics  
Table 1 reports the general phenotypical characteristics of OTR +/+, OTR +/-, OTR -/- 
mutant mice. No significant differences were found in weight, fur condition, piloerection 
body tone and skin colour. Nest building abilities did not differ among different genotypes 
nor did general reflexes (righting, corneal, pinna and tail pinch). No difference was found 
in visual, olfactory, hearing and pain sensitivity (fig. 1) as tested respectively in the visual 
cliff test (fig. 1A), buried pellet test (fig 1B), preyer reflex (fig. C) and hot plate test (fig. 
1D). In particular for the visual cliff test a significant difference between the time spent on 
the plain and check boarded floor side was found by 2way repeated measure ANOVA 
(with side as between-subject factor and genotype as within-subject factor, side x 
genotype interaction: not significant; effect of side: F (1, 28) = 526.3; effect of genotype: 
not significant) followed by Bonferroni post hoc analysis. 
 
5.1.1.2. Motor abilities 
Motor abilities of OTR+/+, OTR +/-, OTR -/- mutant mice are shown in fig. 2. The 
mean number of horizontal (fig. 2A) and vertical counts (fig. 2B) was not different among 
genotypes. Fig 2C reports results of the rotarod test. In the first of the four trials of the test 
a slight not significant difference is shown as a shorter latency to fall from the rotarod is 
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displayed by heterozygous and KO mice cpmpared to WT mice. Recovery from this small 
deficit is reached across the remaining trials as a significant difference from the first trial 
is found (2way repeated measure ANOVA, with trial number as between-subject factor 
and genotype as within-subject factor, treatment x genotype interaction: F (7, 17) = 0.59; 
effect of trial: F (3, 26) = 13.38; effect of genotype: F (2,27) =3.09) followed by Bonferroni 
post hoc analysis. 
No differences among groups were found in the hanging wire test performance as 
measured by the latency to fall from the overturned grid (fig. 2D).  
 
5.1.1.3. Emotional behaviour 
No changes in anxiety or depressive-like behaviour emerged in any of the groups 
tested in our studies: in the elevated plus maze the number (fig. 3A) and time spent (fig. 
3B) in the open arms did not differ among genotypes and time spent immobile was very 
similar also in both the forced swim test (fig. 3C) and tail suspension test (fig. 3D). 
 
5.1.1.4. Social Behaviour 
Social behaviour was evaluated in the sociability and social novelty test 
(respectively fig. 4A-C and fig. 4B-D). One way ANOVA found a significant difference in 
the difference score time in both sociability (F (2, 27) = 9.600, p<0.001) and social novelty 
(F (2, 27) = 23.99, p<0.0001). Tukey‟s post hoc test revealed significant decrease in the 
difference scores for both heterozygous and knock out mice compared to wild type mice 
in both tasks. The number of entries in the different compartments was similar among 
groups (fig. 4C-D). 
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5.1.1.5. Aggressive behaviour 
Alterations of OTR system result in changes in aggressive behaviour of mice (fig. 
5). In the neutral cage test we registered the number of attacks (A) and tail rattlings (C) 
and the latency to the first attack (B) and tail rattling (D). Significant difference was 
revealed by one way ANOVA in the latency to first attack (F (2, 27) = 9.200 , p<0.0003), 
number of attacks (F (2, 27) = 10.51, p<0.0001), latency to first tail rattling (F (2, 27) = 7.2, 
p<0.003) and number of tail rattlings (F (2, 27) = 4.3, p<0.01). In particular Tukey‟s test 
revealed a significant increase in aggressive behaviour in the OTR -/- group in comparison 
with both OTR +/+ and OTR +/- mice in all considered parameters.  
 
5.1.1.6. T maze 
OTR+/+, OTR+/-, OTR-/- mutant mice performance on both the acquisition and 
reversal phase of the T maze task is shown in fig. 5. The above panels show the general 
trend of the % of animals reaching the criterion throughout the testing days in both 
acquisition (A) and reversal (B) phases. The number of days needed to reach the criterion 
is displayed in panel C (acquisition phase) and D (reversal phase) for all genotypes. No 
significant difference is found in the acquisition phase among groups; in the reversal 
phase, ANOVA revealed a significant genotype effect (F (2, 27) = 13.34, p<0.0001) and 
post hoc comparison detected a significant increase in the number of days needed by the 
OTR-/- mice group to reach the criterion compared to both OTR+/+ and OTR+/- group. 
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5.1.1.7. Autoradiography binding assay 
Figure 6 shows the different autoradiographic binding densities of OTR (A) and 
V1aR (B) in different social/emotional-related brain areas of OTR mutant mice. In figure 
6A, statistical analysis performed as two-way ANOVA with brain areas as between-
subject factor and genotype as within-subject factor (brain areas x genotype interaction: F 
(12, 54) = 17.5; effect of areas F (8, 73) = 402.1, effect of genotype F (2, 78) = 62.13) 
found a significant difference. Bonferroni‟s post-hoc analysis revealed a significant 
decrease in OTR density in both heterozygous (in AON, Pyr Ctx, LS, VP, Amy, Hippo and 
SON) and knock out mice (in all tested areas exluding Hyp) compared to the wild type 
group. Furthermore, OTR binding was found to be significantly different between OTR +/- 
and OTR -/- in AON, Pyr Ctx, LS, VP, Amy and Hippo and SON. 
 As for V1aR (fig. 6B), two-way ANOVA with brain areas as between-subject factor 
and genotype as within-subject factor (brain areas x genotype interaction: F (12, 54) = 
2.31; effect of brain areas F (8,73) = 127.6, effect of genotype F (2,78) = 7.96) revealed 
significant differences among genoypes. In particular, Bonferroni‟s post-hoc analysis 
revealed a significant decrease in V1aR density in both heterozygous (in AON and VP) 
and knock out mice (in AON, LS, VP and Amy) compared to the wild type group. 
Furthermore, V1aR binding was found to be significantly different between OTR +/- and 
OTR -/- in Amy. 
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5.1.2 Effects of treatments on OTR mice aberrant behaviours 
 
5.1.2.1. Motor abilities 
No difference was found in spontaneous motor activity following i.c.v. treatment of 
OTR +/+, OTR +/-, OTR -/- mutant mice with OT, AVP, SR and SR+OT 30 minutes for both 
horizontal and vertical counts (fig. 8A-B).  
 
5.1.2.2. Social behaviour 
The effect of the different treatments on sociability and social novelty tests is 
reported in fig. 9. In the sociability task (A), two-way repeated measure ANOVA with 
genotype as between subjects factor and treatment as within-subject factor, found a 
significant difference between groups (genotype x treatment interaction: F (8, 135) = 3.07; 
effect of treatment: F (4, 145) = 18.7; effect of genotype: F (2,147) =16.65) Bonferroni‟s 
post-hoc analysis revealed a significant effect of treatment with both OT and AVP (0.5 
ng/2μl) in reversing both OTR+/- and OTR-/- mice social impairment. Pre-treatment with 
SR49059 (0.5 ng/2μl) was able to antagonize OT‟s beneficial effect. After ICV injection of 
OT or AVP, OTR-/- mice showed a preference for the stranger mouse in the social 
recognition task (fig. 9B) and statistical analysis found a signicant difference between 
groups following different treatments: two-way repeated measure ANOVA, with treatment 
as between-subject factor and genotype as within-subject factor, treatment x genotype 
interaction: F(8, 135) = 4.33; effect of treatment: F (4, 145) = 43.46; effect of genotype: F 
(2,147) =16.36. Bonferroni‟s post-hoc analysis revealed a significant effect of treatment 
with both OT and AVP in reversing KO and heterozygous mice social impairment. 
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Moreover pre-treatment with SR49059 (0.5 ng/2μl) significantly reversed the OT-induced 
improvement in social skills. 
 
5.1.2.3. Aggressive behaviour 
Significant treatment effects were revealed in the number of attacks (fig. 10A) (treatment 
x genotype interaction: F(8, 135) = 3.63; effect of treatment: F (4, 145) = 5.32; effect of 
genotype: F (2,147) =22.40), in the latency to first attack (fig. 10B) (F8, 135) = 2.98; effect 
of treatment: F (4, 145) = 6.50; effect of genotype: F (2,147) =12.19), in the number of tail 
rattlings (fig. 10C) ( F(8, 135) = 4.77; effect of treatment: F (4, 145) = 14.89; effect of 
genotype: F (2,147) =5.14) and in the latency to first tail rattling (fig. 10D) (F(8, 135) = 
7.57; effect of treatment: F (4, 145) = 10.81; effect of genotype: F (2,147) =3.65) by two 
way repeated measures ANOVA with treatment as between-subject factor and genotype 
as within-subject factor in aggressive behaviour. Bonferroni‟s post hoc analysis shows a 
significant decrease in the number of attacks and tail rattlings displayed by knock out 
mutant mice and a significant increase in the latency to the first attack and tail rattling 
following i.c.v. treatment with both OT and AVP. SR49059 had no per se effect but pre-
treatment was able to antagonize OT‟s effect in all considered parameters.  
 
5.1.2.4. T maze 
The general trend of the performance of OTR+/+, OTR+/-, OTR-/- mutant mice following 
i.c.v. injection of vehicle, OT, AVP, SR49059 and SR49059 in association with OT is 
shown in panels A-E of figure 11 expressed as the % of animals reaching the criterion 
throughout the first 12 days of the reversal phase of the T maze task. Poor performance 
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of OTR-/- mice following vehicle treatment improved following both OT and AVP 
treatment. SR alone did not seem to induce any change in animals‟ behaviour per se 
while when administered in association with oxytocin it was able to reverse OT‟s 
beneficial effects. Statistically (two way repeated measures ANOVA with treatment as 
between-subject factor and genotype as within-subject factor), significance was revealed 
in panel F, which shows the number of days needed to reach the criterion in the different 
groups (treatment x genotype interaction: F(8, 135) = 5.40; effect of treatment: F (4, 145) 
= 2.93; effect of genotype: F (2,147) =5.70). In particular, Bonferroni‟s test found a 
significant decrease in the number of days needed to reach the criterion following OT and 
AVP treatment in KO mice, and a significant difference between OT treated KO mice and 
SR+OT treated KO mice, with SR49059, that had no per se effect, antagonizing OT-
induced performance improvement. Finally, OT and AVP treatment on wild type animals 
induced a significant increase in the number of days to reach the criterion, when 
compared to the vehicle-treated group. 
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5.2. Zebrafish 
 
5.2.1. Effects of neurohypophysial hormones on zebrafish social 
behaviour 
 
5.2.1.1. Shoaling preference test 
Figure 12 shows behavioural performance of WT zebrafish in the shoaling test 
expressed as difference between time spent in proximity of the nacre shoal compartment 
and time spent near the WT shoal compartment following i.m. treatment with vehicle, 
oxytocin, isotocin (A) and vasopressin and vasotocin (B). Vehicle treated animals spend 
the majority of the time near the WT-associated compartment showing an innate aversion 
for the nacre shoal group. Isotocin (0.1-10 ng/kg) and OT (5-30 ng/kg) treatments 
increase preference for nacre: in particular a non-linear regression on the log of 
administered doses was found to be statistically symmetrical parabolas (R2 (27)= 0.55, 
p<0.001 for isotocin, R2 (48)= 0.42, p<0.001 for OT). Similarly, as shown in panel B, AVT 
(0.1-30 ng/kg) and AVP (10-40 ng/kg) treatments resulted in significanlty fitted parabolic 
curves (R2 (60)= 0.52, p<0.001 for AVT, R2 (35)= 0.28, p<0.05 for AVP).  
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Discussion 
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6.1. The OTR mutant mouse model 
The OTR-/- mutant mouse has been reported to display specific deficits in social 
behaviour and communication, two core symptoms of ASD, and increased aggression in 
a previous work (Takayanagi et al., 2005).  
In order to confirm and complete the behavioural characterization of both OTR-/-
and OTR+/- mice, we first investigated their general health, reflex and sensory abilities, 
motor function and emotional-like reactivity. Our results show that both mutant genotypes 
displayed normal motor activity, anxiety-like behaviour, and no correlates of depression. 
When tested for sociability, OTR+/+ mice behaved normally spending longer time to 
explore the compartment occupied by the stranger mouse than the empty cage. This 
behavioural response was altered in OTR-/- and OTR+/- mice that did not discriminate 
between the two compartments. Moreover, when subjected to a social recognition test, 
both OTR-/- and OTR+/- mice spent the same time with the stranger and the familiar 
mouse, exhibiting a diminished attitude for social novelty and a decrease in social 
memory in comparison with the wild type littermates. Other factors that could influence 
the transition between chambers, such as locomotor activity and olfactory sensitivity were 
not different between the three genotypes. In the same way, any influence by aberrant 
emotional behaviour such as increased anxiety can be also ruled out by experiments that 
confirmed no difference between genotypes. 
The original trademark of autism (Kanner, 1943) characterized autistic children by 
a dramatic lack of interest in others. Current DSM-IV guidelines recognize the variable 
severity of deﬁcits in social interaction, unusual and inappropriate social approach 
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behaviours and the changes in these symptoms across development (American 
Psychiatric Association, 1994).  
Mice are a highly social species, displaying social investigation of an unfamiliar 
conspeciﬁc (an individual of the same species), communal nesting, sleeping in group 
huddles, aggression directed towards intruders, sexual approach and mating behaviour 
patterns, parental care of the pups and juvenile play (Blanchard et al., 2003; Grant and 
MacIntosh, 1963; Ricceri at al., 2007). Thus, a critical component in a mouse model of 
autism is a quantitative measure of appropriate social interaction: the simple social 
approach task we used is able to let us measure quantitatively the tendency of the 
subject mouse to approach another mouse and engage in social investigation.  
OT‟s involvement in regulation social behaviour is well-known. Male OT KO mice 
fail to develop social memory on both the habituation–dishabituation test (Lee et al., 
2008) and the social recognition test (Ferguson et al., 2001). OTR knock out mutant line 
had already been demonstrated to have impaired social recognition (Takayanagi et al., 
2005). However it is the first time that such impairment is demonstrated in the 
heterozygous line of OTR mutants, indicating that even a minor loss in the presence of 
the OT receptor can lead to a strong deficit in their behavioural phenotype. 
In male mice, social aggressive behaviour is characterized by overt attacks with 
biting on the back or neck of the intruder and by the presence of tail rattlings, i.e. very 
quick tail movements that mice display when a threat is perceived (Krsiak, 1975). Such 
behaviour was only observed in OTR-/- mice. Generally, aggression in rodents is believed 
to be mainly under the control of AVP (Caldwell et al., 2008). The role of OT in controlling 
aggressive behaviour in males is ambiguous. In male squirrel monkeys in a stable 
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dominant-subordinate relationship, OT increases sexual and aggressive behaviours in the 
dominant during interaction with a female and this is blocked following administration of 
OT and the OT antagonist OVTA (Winslow and Insel, 1991). Behavioural studies on 
transgenic mice have not yet given any steady statement about this aspect. OT-/- mice are 
mildly less aggressive than their WT counterparts or heterozygous controls (DeVries et 
al., 1997). However, in a different line of OT-/- mice, another group has reported increased 
aggressive behaviour in the resident-intruder paradigm (Winslow et al., 2000). 
Accordingly to our results, higher levels of aggression have already been reported in OTR 
knockouts generated from non-obligates, which suggests the idea that a lack of prenatal 
activation of the OT system could result in increased aggression later on in adult life 
(Takayanagi et al., 2005). 
Autistic individuals often maintain rigid habits, similar to individuals with obsessive–
compulsive disorders, and frequently show a strong insistence on sameness and difficulty 
in changing a previously established routine (Hollander et al., 2003). We tried to replicate 
this complex pattern of behaviour using the T maze task in which mice were trained to 
establish a habit, and then asked to make a change in the established routine. T maze 
acquisition learning involves ﬁnding a food reward in one of two available locations at 
opposite ends of a T-shaped apparatus. Reversal learning requires the mouse to 
extinguish the location of the reinforce in one arm, and learn a new location of the 
reinforce in the opposite arm. Reversal learning requires different skills than the original 
acquisition learning. The latter serves as a control for general procedural and spatial-
cognitive abilities. Ability of the subjects to switch quickly to the new location is quantified 
by the number of trials required to consistently choose the opposite T maze arm to obtain 
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the food reward. Thus, ability to change, resistance to change and responses to the 
change in routine are measured. We compared the cognitive flexibility of OTR-/-, OTR+/- 
and OTR+/+ mice. Although all three genotypes learned to correctly locate the baited arm 
at comparable rates during acquisition, indicating the absence of alteration in spatial 
memory components, switching the reward position to the opposite arm in the reversal 
learning phase induced a significantly slower learning rate in OTR-/- mice suggesting the 
presence of an impaired cognitive flexibility, strong resistance to change and stereotyped 
behaviour. Our results agree with the recent findings by Blundell et al. (2010) and 
Silverman et al. (2010) who have shown respectively that NL1-deficient mice and BTBR 
mice, both promising models for ASD, exhibit a dramatic increase in repetitive, 
stereotyped grooming behaviour. Furthermore, in a recently published paper (Moy et al., 
2009) NRCAM (Neuronal Cell Adhesion Molecule) null mice are described as an 
interesting ASD model as they display both impaired sociability and altered cognitive 
abilities in the T maze reversal learning phase.  
Oxytocin has been shown to promote the rapid formation of inhibitory synapses in 
hypothalamic GABAergic neurons, thus supporting the view that this neuropeptide can 
contribute to the functional remodelling of synapses (Theodosis et al., 2006). In a similar 
way, the neuronal cell adhesion molecule (NRCAM) has been demonstrated to have an 
important role in axonal guidance and the organization of neural circuitry during brain 
development. Autism has in fact been suggested to reflect an alteration of synaptic 
plasticity and/or neuronal connectivity occurring at the time when higher-order neuronal 
networks are established (Zoghbi 2003; Geschwind and Levitt, 2007). Even if mild mental 
retardation is a common characteristic in autistic patients, autism is not characterized by 
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a global impairment of cognition, whose functions are often spared, or even enhanced, as 
in the Savant syndrome, where „islands of geniality‟ stand out, indicating that only certain 
brain circuits are impaired (Treffert, 2009). Thus, a crucial issue will be to understand 
what are the neural pathways selectively „disconnected‟ in ASD and what common 
features make them so vulnerable.  
Neurochemical mechanisms underlying the cognitive flexibility impairment of OTR-
/- mice are starting to be elucidated. In fact, it has been shown in very recent studies (Sala 
et al., 2010, accepted) that primary cultures of hippocampal neurons from OTR-/- display 
significantly less GABAergic synapses. As just mentioned, it is well known that OT can 
play an important role in modulating synaptic plasticity in several brain areas. OT triggers 
a switch from excitatory to inhibitory GABA activity in the hippocampus immediately 
before birth (Tyzio et al., 2004) to promote the rapid formation of functional GABA 
synapses in the adult supraoptic nucleus (Theodosis et al., 2006) and to remodel 
neuronal-glial interactions in the hypothalamus (Oliet et al., 2010). As it was found that 
hippocampal neurons obtained from OTR-/- mice express a lower percentage of 
GABAergic synapses, it is possible that an imbalance in glutamate/GABA transmission 
could be responsible for a hippocampal, working memory-based, cognitive flexibility 
deficit. Interestingly, Morellini et al. (2010) have recently shown that more efficient 
reversal learning correlates with enhanced GABAergic innervation in the dentate gyrus of 
hippocampus. This report fits nicely with our results showing defective reversal learning 
and decreased hippocampal GABAergic synapses in OTR-/-. In rodents, a circuitry 
between the hippocampus, the prefrontal cortex and the striatum is involved in cognitive 
flexibility (Floresco et al., 2009) and we can also hypothesize that similar 
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GABA/glutamate imbalance in prefrontal and/or striatal areas contributes to the specific 
impairment in reversal learning observed in these animals.  
To assess the effects of OT and AVP administration on ASD-like symptoms, OT 
and AVP were administered i.c.v. to all genotypes. Our results point out how both 
peptides rescued a normal level of social exploration and recognition and that the 
pretreatment with the selective V1aR antagonist SR49059 significantly reversed the OT-
induced improvement. Horizontal locomotor activity, as measured in the spontaneous 
motor activity test, was not different among treatments ruling out any of its possible 
influence on more complex behavioural responses. OT and AVP also reversed the 
aggressive behaviour exhibited by OTR-/- mice, whereas pre-treatment with SR49059 
significantly blocked such effect. Finally, treatment with both peptides reduced reversal 
learning impairment in OTR-/- mice in comparison with the vehicle-treated counterparts, 
rescuing the altered cognitive flexibility of these mice.  
In the brain, OT and AVP bind to and activate three related receptors, all belonging 
to the GPCR superfamily, OTR, V1aR and V1bR. Due to the similarities between OT and 
AVP peptides, that differ for only two out of eight aminoacids, and the high homology in 
their receptor sequences, this peptide/receptor system is not sufficiently selective. In 
particular, OT has been shown to also bind with very good affinity the V1aR subtype, 
acting as a partial agonist (Chini et al., 1996). Thus, since the rescue effects of OT and 
AVP could be blocked by a V1aR antagonist, SR49059, we suggest that OT acted on 
V1aR in our KO animals. The distribution of OTRs and V1aRs seems to occur in different, 
mainly not overlapping regions (Tribollet, 1992; Johnson et al., 1993), indicating that the 
two peptides cooperate in the regulation of complex behaviours by acting at different 
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sites. In order to more deeply investigate this aspect, we checked whether in mutant mice 
an altered expression and/or distribution of V1aR could account for the phenotypical 
rescue that we showed. OTR-/- animals displayed an almost undetectable OTR binding in 
all tested areas. Furthermore, a slight compensatory up-regulation of V1aR in the 
hippocampus and a significant down-regulation of the V1aR expression in AON, Amy, 
and VP and LS were found. As for heterozygous mutants their phenotype appears as 
expected halfway between the wild type and knock out counterparts for OTR binding sites 
and V1aRs binding has been subjected to a slight reduction in ventral pallidum and 
anterior olfactory nucleus only. Affected areas exert a key role in integrating the 
processing of olfactory information that is crucial to regulate social recognition in rodents 
(Choleris et al., 2009). Moreover, in these regions, the OTR/V1aR system seems to be 
both necessary and sufficient to modulate social recognition (Bielsky et al, 2005; 
Ferguson et al., 2001; Landgraf et al., 1995).  
Our data reveal that infusion of OT or AVP to OTR mutant mice completely 
normalizes their social deficits. OT was already reported to rescue social deficits in OT-/- 
and CD38-/- animals in which defective OT production or secretion, respectively, are 
responsible for social impairment, but, in these models, AVP was found to be ineffective 
(Ferguson et al., 2000; Jin et al., 2007). This discrepancy suggests that subtle differences 
exist between OT-/- and OTR-/- mice, one possibly residing in compensatory up- and/or 
down-regulation of V1Rs. OT and AVP cooperate in regulating social behaviour, but it is 
still unknown whether they act independently from each other on neuronal circuits that 
control distinct aspect of social recognition, or they exert their role at different steps along 
common pathways. Our current data showing that OT and AVP acting on V1aR 
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effectively rescue the social deficits of OTR-/- mice suggest that the two peptides act 
cooperatively on distinct sites along the same pathways (Young et al., 2005), as it has 
been shown within the central nucleus of the amygdala, where the stimulation of neuronal 
OTRs in the lateral part inhibits, through a GABA-dependent mechanism, the activity of 
ventral neurons under direct excitatory control by V1aR (Huber et al., 2005).  
OT and AVP administration was also very effective in normalizing the increased 
aggressive behaviour observed in OTR-/- mice. This effect was unexpected because AVP 
is generally considered a promoter of social aggression (de Wied et al., 1993). In fact, 
when injected in the anterior hypothalamus, AVP facilitates aggression (Stribley and 
Carter, 1999), whereas a V1aR antagonist injected in the ventral and lateral 
hypothalamus results in reduced aggression (Winslow 1993). However, the role of AVP 
and V1aR in aggression is far than clear as a V1aR-/- mice line displays normal 
aggression (Wersinger et al., 2997), and, in a rodent line genetically selected for high 
aggressive behaviour, a reduced AVPergic fibre network and a reduced neuronal 
activation were observed in the lateral septum (Veenema et al., 2010), a region very 
enriched in V1aR (Johnson et al., 1993) that is strongly activated during fighting (Siegel et 
al., 2007). As OTRs have been recently found on GABA-positive cells in the lateral 
septum and on serotoninergic neurons of the raphe nuclei (Yoshida et al., 2009), an 
interplay between OT/AVP and serotonin can be hypothesized to differentially regulate 
male versus male aggression in different brain regions.  
Finally, OT and AVP infusion in three-month old OTR-/- mice induce a complete 
rescue of the cognitive flexibility, implying that anatomical substrates and neurochemical 
modulators are entirely intact hence it can be restored by pharmacological treatment. 
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Interestingly, we observed a reduction in the performance of the OTR+/+ animals after OT 
or AVP infusions, indicating that the hyper-stimulation of „normal‟ circuitry have a 
detrimental effect. These results suggest that the selection of patients will play a key role 
in evaluating the result of the treatment with these or similar neuropeptides, the use of 
which should be restricted to those individuals who could really benefit from it. Similarly to 
our results, in a mouse model of syndromic autism, the tsc2+/- mouse model of sclerosis 
tuberosis, learning deficits of adult animals could be rescued by pharmacological 
treatment with rapamycin (Ehninger et al., 2008). However, tsc2+/- and OTR-/- mouse 
models share the potential for pharmacological rescue of cognitive functions well after 
birth. For how long in life the rescue is possible and what may happen with chronic 
treatment are the next issues to address.  
Different groups of researchers are currently working trying to investigate the 
complete behavioural phenotype of OTR mutant mice. Very recently (2010) Schorscher-
Petcu et al., have characterized the phenotype of both OTR and V1aR null mutant mice in 
a battery of pain assays. OTR knock-out mice displayed a pain phenotype identical to 
their wild-type littermates, accordingly to our results. Moreover, systemic administration of 
OT dose-dependently produced analgesia in both wild-type and OTR knock-out mice in 
three different assays, the radiant-heat paw withdrawal test, the von Frey test of 
mechanical sensitivity, and the formalin test of inflammatory nociception. Interestingly, 
OT-induced analgesia was completely absent in V1aR knock-out mice and could be fully 
prevented by pretreatment with a V1AR but not an OTR antagonist suggesting the 
interaction between these two strictly connected systems in the modulation of pain 
sensitivity, too. 
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While no animal model can be expected to replicate the full complexity of the 
human behavioural autistic phenotype, a model that selectively exhibit features of all core 
symptoms of autism may be instrumental to understand the 
neurochemical/neuroanatomical basis for the co-occurrence of these symptoms as a 
syndrome. Moreover, the presence of a social deficit in OTR heterozygous mutant mice 
could lead to the use of this particular model as a tool in future drug discovery studies 
meant to find new OTR-directed molecules that could rescue this aberrant phenotype. 
 
6.2 The zebrafish model 
Our results suggest that the OT/AVP system seems to be also involved in social-
related behaviours in non-mammalian species. In the shoaling preference task, WT 
zebrafish increased the time spent in proximity of the usually neglected Nacre mutant 
following treatment with OT and AVP and with their respective non-mammalian 
homologues Isotocin (ISO) and Vasotocin (AVT). At the tested dosed we did not observe 
any effect of the peptides in swimming activity (data not shown) so any non-specific effect 
on arousal or motor functioning can be ruled out. Our data are the first to demonstrate a 
specific pro-social effect of these peptides on the zebrafish model. As expected ISO and 
AVT acted as far more specific peptides than OT and AVP, reaching their peak effect 
respectively at a 20 and 30 times lower concentration than their mammalian homologues. 
Interestingly, all four peptides showed a parabolic trend in their dose-effect curves, with 
lowest and highest doses exerting no effect at all: the reason for that could be that the 
lowest drug concentrations might not be sufficient to engage an adequate number of 
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receptors in order to induce a pro-social response; highest doses, instead, might be 
responsible for the presence of non-specific side effects such as anxiety-related 
responses. Of course this hypotheses must be validated by specific future experiments  
on emotional responses induced by these peptides. 
It has been shown that as with oxytocinergic neurons of mammals, isotocinergic 
neurons project widely in the brain of trout (Saito et al., 2004) and zebraﬁsh (Khan et al, 
2010). Moreover, isotocin and vasotocin inﬂuence social and reproductive behaviours in 
ﬁsh (Goodson and Bass, 2000, 2001) much like the equivalent hormones in mammals. 
Previous studies involving fish behaviour and OT/AVP/ISO/AVT systems have revealed 
their crucial role in influencing social-related behavioural responses. Thompson and 
Walton in 2004 measured the effects of centrally infused peptides on social approach in 
the social teleost goldfish (Carassus auratus). Vasotocin inhibited approach responses 
toward the visual stimuli of conspecifics and a V1 receptor antagonist stimulated such 
responses in animals that were not highly social in baseline conditions, as did isotocin. 
These experiments indicate that AVT and ISO induce opposite effects on social approach 
responses in male goldfish. Discrepancies may be found as these studies are far from 
being completely exhaustive: still no isotocin or vasotocin receptors have been located in 
zebrafish so it is not clear which is the mechanism behind the effect of these peptides. 
Very recently Khan and colleagues (2010) have revealed that the novel and brain specific 
cyclic nucleotide gated channel alpha subunit, CNGA5, is enriched in synaptic terminals 
of isotocinergic neurons in zebraﬁsh brain and in particular in the neurohypophysis. Cyclic 
nucleotide gate channels have been reported to modulate transmitter release at synaptic 
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terminals and CNGA5 channels seem thus to be important presynaptic modulators of 
neuroendocrine systems that inﬂuence reproductive and social behavior in zebraﬁsh.  
Of course our study does not aim at elucidating the mechanisms that regulate 
zebrafish social behaviour. Here, our aim was instead to show how this behaviour can 
easily be modulated through pharmacological treatments and how this small teleost can 
be used as a model to investigate potential pro-social effects of novel drugs especially as 
a large-scale screening tool prior to engage expensive and time-consuming researches 
using the classical rodent models. 
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Figures 
 
General Health and Characteristics
OTR+/+ OTR+/- OTR-/-
General Health
Weight (g)
Fur condition (3-point scale)
Piloerection (%)
Body Tone (3-point scale)
Skin colour (%)
31.0 0.5
3.0 0.0
0
2.0 0.0
100
29.2 0.4
3.0 0.0
0
2.0 0.0
100
31.1 0.4
3.0 0.0
0
2.0 0.0
100
Empty cage behaviour
Nest building (5-point scale) 3.8 0.4 4.0 0.3 4.1 0.3
Reflexes
Righting reflexes (4-point scale)
Corneal (8-point scale)
Pinna (8-point scale)
Tail pinch (8-point scale)
0.05 0.05
3.9 0.2
3.9 0.1
3.9 0.1
0.02 0.02
3.8 0.2
3.8 0.2
3.9 0.04
0.04 0.04
4.0 0.0
3.9 0.04
3.98 0.2
Table 1: General phenotypic characteristics, empty cage behaviour and reflexes of OTR+/+, OTR+/- and OTR-/- mutant mice
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Sensory Abilities
Fig 1: sensory abilities of OTR wild type, heterozygous and knock out mice as evaluated in the visual cliff test (A), buried
pellet test (B), preyer reflex test (C) and hot plate test (D) (mean SEM). *** p<0.001 vs time spent on the check boarded
side (2way ANOVA, Bonferroni’s test).
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Motor Abilities
Fig 2: motor abilities (mean SEM) of OTR+/+, OTR+/-, OTR-/- mice as evaluated in an activity cage measuring horizontal (A)
and vertical (B) counts, in the rotarod test (C) and hanging wire test (D). *p<0.05, **p<0.01, ***p<0.001 vs 1st trial (2way
ANOVA, Bonferroni’s test)
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Emotional Behaviour
Fig 3: genotype effect (mean SEM) in OTR+/+, OTR+/-, OTR-/- mice on emotional behaviour evaluated in the elevated plus
maze as open arm entries (A) and time (B), in the forced swim test (C) and tail suspension test (D) as time spent immobile.
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Social Behaviour
Fig 4: social behaviour of OTR+/+, OTR+/-, OTR-/- mice displayed in the sociability (A-C) and social novelty test (B-D)
expressed as mean SEM of the difference score and number of entries made in the different compartments. ** p<0.01, ***
p<0.001 vs OTR +/+ (ANOVA, Tukey’s test).
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Aggressive behaviour
Fig 5: aggressive behaviour of OTR+/+, OTR+/-, OTR-/- mice in the neutral cage test. Mean SEM of the latency to first
attack and tail rattling is shown in panels A and C, the number (mean ± SEM) of attacks and tail rattling in panels B and D.
* p<0.05, ** p<0.01, *** p<0.001 vs OTR +/+ , °° p<0.01, °°° p<0.001 vs OTR +/- (ANOVA, Tukey’s test).
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T-maze
Fig 6: OTR+/+, OTR+/-, OTR-/- mice performance in both the acquisition (A-C) and reversal phase (B-D) of the T maze task.
Data are expressed as % of animals reaching the criterion (A-B) and number of days (mean SEM) needed to reach the
criterion (C-D). *** p<0.001 vs OTR +/+ , °°° p<0.001 vs OTR +/- (ANOVA, Tukey’s test).
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Fig 7: brain expression of OTR (A) and V1aR (B) as results by the quantification of the autoradiographic receptor binding
in 9 different brain areas of OTR +/+, OTR +/-, OTR -/- mice. *P<0.05, **P<0.01, ***P<0.001 vs OTR +/+, ° p<0.05, °° p<0.01,
°°° p<0.001 vs OTR +/- (2way ANOVA, Bonferroni’s test)
AON, Anterior Olfactory Nucleus, VDB, vertical limb of the diagonal band, PyrCtx, Pyriform Cortex, LS, Lateral Septum, VP,
ventral Pallidum, Hyp, Hypothalamus, Amy, Amygdala, Hippo, Hippocampus, SON, Supraoptic Nucleus.
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Motor Abilities: treatments
Fig 8: motor abilities of OTR+/+, OTR+/-, OTR-/- mice expressed as horizontal (A) and vertical (B) counts following i.c.v.
administration of vehicle (V), oxytocin (OT), vasopressin (AVP), SR49059 alone (SR) or in association with oxytocin (SR +
OT).
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Social behaviour: treatments
Fig 9: performance by OTR+/+, OTR+/-, OTR-/- mice on the sociability (A) and social novelty (B) tests following i.c.v.
administration of vehicle (V), oxytocin (OT), vasopressin (AVP), SR49059 alone (SR) or in association with oxytocin (SR +
OT). * p< 0.05, ** p< 0.01, *** p<0.001 vs V; ° p<0.05, °°° p<0.001 vs OT (2way ANOVA followed by Bonferroni’s test).
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Aggressive behaviour: treatments
Fig 10: aggressive behaviour evaluated in the neutral cage test as number of attack and tail rattlings (A-C) and latency to
first attack (B) and tail rattling (D) following i.c.v. administration of vehicle (V), oxytocin (OT), vasopressin (AVP), SR49059
alone (SR) or in association with oxytocin (SR + OT). * p< 0.05, ** p< 0.01, *** p<0.001 vs V; °° p<0.01, °°° p<0.001 vs OT
(2way ANOVA followed by Bonferroni’s test).
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T-maze: treatments
Fig 11: OTR+/+, OTR+/-, OTR-/- mice performance in the reversal phase of the T maze task following i.c.v. administration of
vehicle (V) (A), oxytocin (OT) (B), vasopressin (AVP) (C), SR49059 alone (SR) (D) or in association with oxytocin (SR + OT)
(E) expressed as % of animals reaching the criterion. The number of days taken to reach the criterion is shown in panel F.
* p<0.05, *** p<0.001 vs V , p<0.001 vs OT (2 way ANOVA, Bonferroni’s test).
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Fig 12: social behaviour of WT zebrafish 10 minutes following i.m. administration of vehicle (V) and different doses of
oxytocin (OT), isotocin (ISO) (A), vasopressin (AVP), vasotocin (AVT) (B).
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